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“[With the pain] I didn’t have the desire to do anything. I wasn’t
hungry and didn’t want to walk…nothing. It would anger me when
people spoke to me… [With palliative care] I have come back to life.” 
– Remedios Ramirez Facio, a 73-year-old woman with pancreatic cancer 
who receives palliative care at Mexico’s National Cancer Institute. 
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Summary 
 
Almost 600,000 people die every year in Mexico, nearly half of them as a result of chronic 
illnesses such as heart and lung disease, diabetes, HIV or cancer. Hundreds of thousands 
more Mexicans battle with earlier stages of these and other chronic illness. Over the 
course of their illness many of these people experience debilitating symptoms such as 
pain, breathlessness, anxiety and depression. To ensure proper medical care for many of 
these individuals, access to palliative care and pain medicines is essential. Without these 
services, they will suffer needless pain and distress undermining their quality of life and 
that of their families in their final days of life.  
 
In Mexico, access to palliative care services and to medicines essential for pain treatment 
is very limited. Human Rights Watch found that currently only a few dozen public 
healthcare institutions in the country offer palliative care and even fewer provide it in 
patients’ homes. Most healthcare personnel have received no training in the discipline, 
and few doctors are licensed to prescribe strong pain medicines that are essential for 
palliative care. Where palliative care is available it is often due to the efforts of individual 
physicians or advocates rather than the result of a deliberate policy of the government, 
health system or insurer. 
 
Palliative care seeks to control pain and other physical symptoms and address 
psychosocial and spiritual issues people with life-limiting illnesses and their families face. 
The World Health Organization (WHO) considers palliative care an essential part of the 
healthcare system and recommends that countries implement health policies to promote it, 
ensure adequate training of health professionals, and make essential palliative care 
medicines, including opioid analgesics, accessible. As palliative care does not require 
expensive equipment or medications it can generally be provided at a relatively low cost. A 
wealth of research studies has shown the effectiveness of palliative care and some studies 
have found that offering palliative care leads to overall cost savings for health systems due 
to reductions in the use of emergency health services and hospital admissions. The 
effectiveness of opioid analgesics, essential medicines for treatment of moderate to 
severe pain that are inexpensive and easy to administer, is equally proven, and in high 
income countries, they are widely available and used to address pain. 
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This report identifies challenges people with life-limiting illnesses in Mexico face 
accessing palliative care, with a special focus on access to pain treatment. The report is 
based on the research Human Rights Watch conducted in Mexico from 2011 to 2014, 
interviewing 115 patients, their family members, healthcare workers and government 
officials in Mexico City and the states of Chiapas, Jalisco, Mexico and Nuevo León. We also 
reviewed relevant legislation, insurance policies, medicines lists and other policy 
documents. 
 
Seven of Mexico’s thirty-two states—Coahuila, Guerrero, Hidalgo, Quintana Roo, Sinaloa, 
Tlaxcala and Zacatecas—do not have any known palliative care services. Another 
seventeen states have just one palliative care service, in the capital city in each case. For 
many Mexican residents, at the moment when they are most desperately ill, frail, and in 
intense pain, care is not available at all or only hours away by public transport. Opioid 
analgesics for chronic pain such as morphine are also almost completely unavailable 
outside state capitals. 
 
As a result, many patients end up without access to palliative care, even if their insurance 
entitles them to such care. We found that in Mexico City and only three states (Durango, 
Guanajuato, and Jalisco), do patients with insurance from Mexico’s largest three health 
insurers —Seguro Popular, the Mexican Social Security Institute (IMSS) and State’s 
Employees’ Social Security and Social Services Institute (ISSSTE)—have hospitals in their 
states that are both in their networks and offer palliative care and/or have a pain clinic. 
 
In terms of training, only six of Mexico’s 135 medical schools teach courses on palliative 
care for undergraduate medical students—these courses are mandatory in just two. As a 
result, many physicians and other healthcare workers do not have even basic skills in the 
care of patients who require palliative care. 
 
The lack of availability of opioid pain medicines is due in part to insufficient training but 
also to complex prescription requirements that discourage physicians from obtaining the 
license needed to prescribe these medicines and pharmacies from stocking them. 
Mexico’s health law requires physicians to use not just special prescription forms for 
opioid medicines but also barcoded stickers—an unusual requirement. These barcoded 
stickers can currently only be obtained in one place in every Mexican state and must be 
picked up in person, making this requirement highly burdensome to meet. This has 
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resulted in the vast majority of doctors, especially those living outside state capitals, not 
being authorized to prescribe these medicines. The government has announced it will 
replace this system to ensure easier access to barcoded stickers for physicians. 
 
Even when patients find a physician able to prescribe these medicines, they face 
difficulties filling prescriptions. Very few pharmacies, especially outside state capitals, 
stock these medicines because almost no physicians outside state capitals can prescribe 
them and because of administrative requirements for licensing and record keeping. 
Furthermore, current dispensing regulations frequently force pharmacies to refuse to fill 
prescriptions on technical grounds forcing patients to return to their physicians to pick up 
new ones. 
 
In January 2009, Mexico added a section on palliative care to its health law, granting 
people with terminal illness—defined as people with a prognosis of six months or less—
the right to palliative care at healthcare institutions and at home. It grants them a right to 
information about their illness and prognosis and allows them to make decisions about 
medical care at the end of life, including a right to refuse life-prolonging treatment. 
 
Under the law, all healthcare providers must develop treatment plans that address the 
individual needs of terminal patients and their families. Care must be provided by 
multidisciplinary teams that include not just physicians but also nurses, psychologists and 
other healthcare workers. The law obliges healthcare institutions to ensure that their 
personnel is adequately trained and that they have an adequate supply of medicines to 
treat pain and other symptoms. 
 
These provisions of the health law were passed in recognition of the changing 
demographics and health burdens facing Mexico. While Mexico is still a relatively young 
nation, a rapid demographic shift is expected to occur in the next few decades. In 2010, 
only 7.1 million Mexicans were 65-years-old or older. By 2020, that number will reach 9.8 
million, and by 2050, 23.1 million. Meanwhile the prevalence of chronic illnesses, such as 
cancer, heart disease and diabetes is on the rise and will continue to increase as a result 
of, among others, the aging process. By developing palliative care services now, Mexico’s 
healthcare system can prepare itself for the wave of patients with chronic illnesses that 
will seek health services in years to come. 
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The palliative care provisions in the law are ambitious as they seek the full integration of 
palliative care into health services, but build upon Mexico’s success in achieving near 
universal health coverage for its population through a combination of public, employer-
based and private health insurance. Unfortunately, five years after the 2009 changes to 
the law, the intended results have yet to materialize. 
 
The law requires a radical shift of the status quo. What is now ad hoc must become an 
integral part of the health system. This will require the development of the infrastructure 
within the health system capable of delivering palliative care; assigning and training 
sufficient numbers of healthcare workers; and the integration of palliative care into 
financing structures and insurance packages. It will also require changes in drug 
regulations and medicine policies to ensure the adequate availability and accessibility of 
opioid pain medicines. None of this can happen without the active stewardship of the 
Mexican government based on a step-by-step integration plan that identifies effective 
delivery models, puts into place the necessary regulatory framework to facilitate the 
process and holds institutions accountable for meeting requirements. Until recently, the 
government had not undertaken any of these steps. 
 
However, in 2013, the situation began to change as both Mexican civil society and the 
government took up palliative care as a priority. A number of key meetings and an 
international seminar, organized by the Mexican Health Foundation (Fundación Mexicana 
para la Salud), the breast cancer organization Tómatelo a Pecho, and the National 
Autonomous University of Mexico served as catalysts for a number of important policy 
initiatives. Civil society has been able to work closely with high-level policy makers and 
leading legislators.  
 
In November 2013, Mexico’s president Enrique Peña Nieto signed a regulation that clarifies 
the content of a number of palliative care provisions in the health law. In March 2014, 
Health Minister Mercedes Juan López instructed her ministry to develop a national 
palliative care strategy. In March 2014, the ministry of health and the Federal Commission 
for the Protection against Health Risks (Comisión Federal para la Protección contra Riesgos 
Sanitarios, COFEPRIS), Mexico’s regulatory agency for medicines, announced critical 
reforms to the system for prescribing and dispensing strong pain medicines, as well as 
record keeping. That same month, the National Commission for Social Protection in Health, 
which runs Seguro Popular, one of Mexico’s largest health insurance programs, added a 
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number of key palliative care interventions to its package. It had previously not covered 
palliative care for most patients. Following an internal review, the Mexican Social Security 
Institute recently announced its intention to strengthen availability of palliative care within 
its system. 
 
Finally, the health ministry is finalizing implementing norms for the 2009 amendments to 
the health law, which are expected to be released in October 2014, and the Public Health 
Council (Consejo Nacional de Salubridad) is preparing an agreement between different 
government agencies on the development of palliative care. 
 
If these steps are properly implemented, Mexico seems poised for change. Its roll-out of 
universal health coverage provides a healthcare system into which palliative care can be 
integrated. Moreover, a number of successful models for the delivery of palliative care 
already exist. For example, under Governor Enrique Peña Nieto, Mexico’s current president, 
Mexico State launched a state palliative care program in 2009 focused on developing 
decentralized services throughout the state and training healthcare workers, which 
resulted in the creation of palliative care units in nine hospitals around the state. Another 
key model was developed by a hospital of the Mexican Social Security Institute (IMSS), 
Mexico’s largest health insurer, in Monterrey, Nuevo León, and allows patients to receive 
palliative care close to their homes through involvement of primary care providers.  
 
These steps are in line with Mexico’s obligations under international human rights law, 
which require it to take action to remove barriers facing patients who need access to 
palliative care. Both the International Covenant on Economic, Social and Cultural Rights, 
which Mexico ratified in 1981, and the prohibition of torture, cruel, inhuman and degrading 
treatment in the International Covenant on Civil and Political Rights, also ratified in 1981, 
can be understood as obligating the government of Mexico to act expeditiously to ensure 
access to palliative care and pain medicines. The well-being of hundreds of thousands of 
people in Mexico, who seek dignity and peace in their final days, depends upon the 
government accelerating action on the implementation of the 2009 health law reforms and 
realizing the goal of an integrated system of palliative care nationwide.  
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Recommendations 
 
The implementation of the law will require a progression of actions that address several 
key challenges. First, the normative and conceptual basis for Mexico’s palliative care 
system needs to be finalized. The law and regulation decide many big picture legal and 
conceptual questions but do not offer a specific model for the delivery of palliative care 
and leave a number of legal questions unresolved. Secondly, the healthcare system itself 
needs to be prepared to support and deliver palliative care services. This means that 
palliative care needs to be incorporated into insurance packages and financing structures 
and integrated into educational programs for healthcare workers. Finally, Mexico will need 
to build the delivery system for palliative care by setting up services, training existing 
healthcare workers and creating referral systems. 
 
As noted above, the Mexican government has taken a number of encouraging steps to 
integrate palliative care into the country’s health system. We welcome its commitment to 
ensure people with life-limiting illnesses do not have to face unnecessary suffering. To 
help make palliative care available to all people in Mexico who need it, we believe the 
following steps are essential: 
 
Finalize Legal Base and Interpretation of the Law 
The palliative care chapter in the health law leaves the interpretation of key provisions and 
guidance on implementation to the discretion of the health ministry. According to the law, 
the ministry was mandated to provide the official implementation norm by mid-2009 but 
has yet to do so. The ministry is currently finalizing the norm, which is expected to be 
published in October 2014. Among others, the norm should create a clear legal and 
conceptual basis to facilitate palliative care for adults and children in the home and by 
primary care providers. 
 
The law currently does not cover palliative care for people with a prognosis of more than 
six months of survival. Yet, under international law these people have a right to palliative 
care if they meet clinical criteria for it. The government should reform the law to ensure 
these patients have access to adequate palliative care regardless of diagnosis or 
prognosis. 
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Develop Models of Care 
The government needs to decide what model(s) of care should be used in public 
healthcare institutions in Mexico. In particular, it needs to determine: 
 
• the role of primary care givers in the provision of palliative care;  
• how home-based palliative care will be provided; 
• what referral mechanisms should be put in place; 
• how palliative care should be covered through health insurance policies; and  
• what models of palliative care are most effective to meet the needs of children with 
life-limiting illnesses. 
 
Adapt Healthcare System to Deliver Palliative Care 
Based on the normative basis and models of care chosen, the government should take 
steps to prepare the health system to start delivering palliative care. Among key steps 
required are: 
 
• adapt medicines lists to include all essential palliative care medicines; 
• include palliative care interventions in insurance packages; 
• implement the new system for prescribing opioid medications; 
• include palliative care, including for children, in undergraduate training curricula 
for students of medicine, nursing, psychology, social work, and pharmacy. 
 
Building the Delivery System 
Finally, the government should ensure that the delivery system for palliative care is 
developed. To facilitate that process, it should: 
 
• allocate funds to allow hospitals and clinics to set up palliative care services, 
referral systems, and train staff; 
• specify requirements and timeframes hospitals and clinics must meet in rolling out 
palliative care. 
• put in place a strong accountability system to monitor the development of 
palliative care by different parts of the system and allow for appropriate 
adjustments or other remedial action when requirements and timeframes are not 
met.  
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Methodology 
 
This report is based on research conducted between September 2011 and February 2014, 
including field visits to Mexico in September and October 2011, February and April 2012, 
and February and October 2013. Field research was conducted primarily in the states of 
Jalisco and Chiapas as well as in Mexico City. We chose these locations for research 
because of their geographic diversity, with Jalisco situated in Western Mexico, Chiapas in 
the south, and Mexico City in Central Mexico. Additional research was conducted in the 
city of Monterrey, Nuevo León, a state in Northern Mexico. We also performed additional 
research in Mexico State because of its government’s proactive efforts to develop 
palliative care. We also conducted extensive desk research regarding palliative care 
availability in various other parts of the country. 
 
Over a cumulative total of eight weeks in Mexico, a Human Rights Watch researcher 
conducted 115 interviews with a wide variety of stakeholders, including 74 people with 
cancer, HIV/AIDS, and other life-limiting health conditions, or their relatives; 24 healthcare 
workers, including oncologists, anesthesiologists, palliative care doctors; 12 pharmacists 
or pharmacy personnel; and representatives of two pharmaceutical companies. 
 
Interviews with patients and their relatives were conducted at their homes or in palliative 
care units at hospitals. Interviews were conducted in private whenever possible. Interviews 
were semi-structured and covered a range of topics related to palliative care and pain 
treatment. Before each interview we informed interviewees of its purpose, informed them 
of the kinds of issues that would be covered, and sought their consent before proceeding 
with the interviews. 
 
Interviewees were informed that they could discontinue the interview at any time or 
decline to answer any specific questions, without consequence. No incentives were 
offered or provided to persons interviewed. We have disguised the identities of all patients, 
relatives and healthcare workers we interviewed in this report to protect their privacy, 
except when they specifically agreed that their real name could be used. 
 
The Human Rights Watch researcher who led the research conducted almost all the 
interviews in Spanish, and was assisted by a Mexican psychologist with palliative care 
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experience. A few interviews were conducted in English because the interviewee spoke 
English fluently. 
 
Human Rights Watch also submitted 24 requests for information under Mexico’s freedom 
of information act, including one to Comisión Federal para la Protección contra Riesgos 
Sanitarios (COFEPRIS), one to the customs agency, and 22 to Mexico’s states. We were 
unable to submit requests to the remaining nine states because their websites were either 
not functional or did not allow us to submit the requests. We received responses from 
COFEPRIS and 15 states. COFEPRIS’ response also covered Mexico City and Nuevo León. 
 
In June 2012, Human Rights Watch presented preliminary findings to the then minister of 
health, officials at the Federal Commission for the Protection against Sanitary Risks 
(COFEPRIS), and the National Commission for Social Protection in Health (NCSPH), which 
runs Seguro Popular. Between April 2013 and June 2014, Human Rights Watch presented 
preliminary findings to various officials of the new administration, including two deputy 
health ministers, the head of COFEPRIS, and officials at NCSPH, IMSS, and ISSSTE. 
 
While the report focuses primarily on the availability of palliative care, various sections of 
this report examine the situation with pain treatment and pain clinics. Palliative care 
services and pain clinics are not the same. The former focuses not just on management of 
pain but also on other physical, psychosocial, and spiritual problems whereas the latter 
focuses not just on patients with life-limiting illnesses but also on those with acute or 
chronic pain problems. 
 
All documents cited in the report are either publicly available or on file with Human Rights 
Watch. 
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Human RIghts Watch conducted research in:
Chiapas, Jalisco, Mexico City, Mexico State, and Nuevo Leon.
I. BACKGROUND
THE IMPORTANCE OF PALLIATIVE CARE
Palliative care seeks to improve the quality of life of
patients, both adults and children, facing life-limiting
or terminal illness. Its purpose is not to cure a patient
or extend his or her life. Palliative care prevents and
relieves pain and other physical and psychosocial
problems. Dame Cicely Saunders, the founder of the
first modern hospice and a lifelong advocate for pal-
liative care, points out that palliative care is about
“adding life to the days, not days to the life.” The
World Health Organization (WHO) recognizes palliative
care as an integral part of healthcare that should be
available to those who need it.1 While palliative care
is often associated with cancer, a much wider circle of
patients with health conditions can benefit from it, in-
cluding patients in advanced stages of neurological
disorders, cardiac, liver or renal disease.2
One key objective of palliative care is to offer pa-
tients treatment for their pain. Chronic pain is a com-
mon symptom of cancer and HIV/AIDS, as well as other
health conditions, especially in the terminal phase of
illness.3 The WHO estimates that around 80 percent of
both cancer and AIDS patients and 67 percent of both
patients with cardiovascular diseases and chronic pul-
monary diseases will experience moderate to severe
pain at the end of life.4
Moderate to severe pain has a profound impact on
quality of life. Persistent pain has a series of physical,
psychological, and social consequences. It can lead to
reduced mobility and consequent loss of strength;
compromise the immune system; and interfere with a
person’s ability to eat, concentrate, sleep, or interact
with others.5 A WHO study found that people who live
with chronic pain are four times more likely to suffer
from depression or anxiety.6 The physical effect of
chronic pain and the psychological strain it causes can
even influence the course of disease, as the WHO notes
in its cancer control guidelines, “Pain Can Kill.”7 Social
consequences include the inability to work, care for
oneself, children or other family members, participate
in social activities, and find closure at the end of life.8
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A wealth of research studies has shown the effective-
ness of palliative care and some studies have found
that offering palliative care leads to overall cost savings
for health systems due to reductions in use of emer-
gency health services and hospital admissions.9
According to the WHO, “Most, if not all, pain due to
cancer could be relieved if we implemented existing
medical knowledge and treatments” (original empha-
sis).10 The mainstay medication for the treatment of
moderate to severe pain is morphine, an inexpensive
opioid that is made of an extract of the poppy plant.
Morphine can be injected, taken orally, delivered
through an IV or into the spinal cord. It is mostly in-
jected to treat acute pain, generally in hospital settings.
Oral morphine is the medicine of choice for chronic can-
cer pain, and can be taken both in institutional settings
and at home. Morphine is a controlled medication,
meaning that its manufacture, distribution, and dis-
pensing is strictly regulated both at the international
and national levels.
Medical experts have recognized the importance of
opioid pain relievers for decades. The 1961 Single Con-
vention on Narcotic Drugs, the international treaty that
governs the use of narcotic drugs, explicitly states that
“the medical use of narcotic drugs continues to be in-
dispensable for the relief of pain and suffering” and
that “adequate provision must be made to ensure the
availability of narcotic drugs for such purposes.”11 The
World Health Organization has included morphine in its
Model List of Essential Medicines, a list of the minimum
essential medications that should be available to all
persons who need them, since it was first established.12
Yet, approximately 80 percent of the world population
has either no or insufficient access to treatment for
moderate to severe pain and tens of millions of people
around the world, including around 5.5 million cancer
patients and one million end-stage HIV/AIDS patients,
suffer from moderate to severe pain each year without
treatment.13
But palliative care is broader than just relief of phys-
ical pain. Other key objectives of palliative care may in-
clude the provision of care for other physical symptoms
as well as psychosocial and spiritual care to both the
patient and their family. Life-limiting illness is fre-
quently associated with various other physical symp-
toms, such as nausea and shortness of breath, that
have significant impact on a patient’s quality of life. Pal-
liative care seeks to alleviate these symptoms.
People with life-limiting illness and their relatives
often confront profound psychosocial and spiritual
questions as they face life-threatening or incurable and
often debilitating illness. Anxiety and depression are
common symptoms.14 Palliative care interventions like
psychosocial counseling have been shown to consid-
erably diminish incidence and severity of such symp-
toms and to improve the quality of life of patients and
their families.15
The WHO has urged countries, including those with
limited resources, to make palliative care services avail-
able. It recommends that countries prioritize imple-
menting palliative care services in the
community—providing care at people’s homes rather
than at healthcare institutions—where it can be pro-
vided at low cost and where people with limited access
to medical facilities can be reached, and in medical in-
stitutions that deal with large numbers of patients re-
quiring palliative care services.16
In recent years, the WHO and the World Bank have
urged countries to implement free universal health cov-
erage to ensure that all people obtain the health serv-
ices they need without suffering financial hardship
when paying for them.17 Palliative care is one of the
basic health services that the WHO and the World Bank
say should be available under universal health cover-
age, along with “promotive, preventive, curative, and
rehabilitative” health services.18
While Mexico is still a relatively young nation, a rapid
demographic shift is expected to occur in the next few
decades. In 2010, only 7.1 million Mexicans were 65-
years-old or older. By 2020, that number will reach 9.8
million and by 2050 23.1 million.19 Meanwhile the
prevalence of chronic illnesses, such as cancer, heart
disease and diabetes is on the rise and will continue to
increase as a result of, among others, the aging
process. Thus, Mexico’s healthcare system can expect
a wave of patients with chronic illnesses that will seek
health services in years to come.
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MEXICO’S HEALTHCARE SYSTEM
In 2003, Mexico reformed its healthcare system to
provide insurance for millions of its uninsured citi-
zens.20 Following these reforms, it has achieved near
universal health insurance coverage.
Prior to the reform, Mexico only provided health in-
surance through social security schemes targeted to-
ward salaried workers in the formal sector of the
economy and civil servants. Two social security pro-
grams—the Mexican Social Security Institute (IMSS) and
the Institute of Social Security and Services for Govern-
ment Workers (ISSSTE)—insured approximately 50 mil-
lion people.21 Moreover, a small percentage of Mexicans
were covered by private insurance.22 Yet, the social se-
curity schemes and private insurance left approximately
half of Mexico’s more than 110 million person popula-
tion uninsured—principally low-income and unem-
ployed individuals.23
The uninsured faced impoverishing out-of-pocket
costs, ill-defined benefits, and medicine shortages due
to budgetary limitations.24 Thus, as Dr. Julio Frenk, for-
mer Secretary of Health of Mexico, and others observed
in an article in Lancet: “[The] Mexican health system
was organized around a segmented model…and
marked by the separation of health-care rights between
the insured in the salaried, formal sector of the econ-
omy and the uninsured.”25
Seeking to reduce and eventually eliminate segmen-
tation in the provision of healthcare services, Mexico
created Seguro Popular, a publically subsidized health
insurance plan available to Mexicans not covered by a
social security scheme or private insurance.26 Seguro
Popular provides a specific package of personal health-
care interventions and medicines at the primary and
secondary levels of care.27 As of 2014, the package—the
Universal Catalogue of Health Services—contains 285
healthcare interventions.28 Additionally, people cov-
ered by Seguro Popular are eligible to receive care for
an enumerated list of complex medical procedures, in-
cluding treatment for pediatric cancers and HIV, through
the Fund for the Protection against Catastrophic Costs
(Fondo de Protección contra Gastos Catastróficos).29 As
of 2013, Seguro Popular provided health insurance to
approximately 55.6 million Mexicans.30
Under the current healthcare system, each social se-
curity scheme and the Seguro Popular are vertically in-
tegrated. In other words, each insurance scheme
maintains their own source of funds, service packages,
and system of hospitals and clinics. 31 The fragmenta-
tion of Mexico’s insurance schemes creates disparate
standards and operating norms at health institutions
across the country.32 Moreover, since Mexico’s health
insurers do not cross-honor the policies of the other in-
surers, patients may be denied access to services at
certain hospitals because of the type of insurance they
hold.
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REMEDIOS RAMÍREZ FACIO’S STORY
Remedios Ramírez Facio (73) lives on a small plot of
land in Atitalaquia, a village in the state of Hidalgo in
Central Mexico near one of the country’s largest oil re-
fineries.33 She and her husband live in a small one-
story brick building, painted bright orange, with
corrugated roofs. In front, there is an open area with a
table and some chairs where much of the family’s life
transpires. On the other side of their property live
Ramírez’s animals: dogs, chickens, ducks, and several
large pigs. Closer to the road, a visitor’s eyes are drawn
to a colorful wall display of plants and flowers; these
were more beautiful, Ramírez says, before she fell ill
with cancer.
Ramírez and her husband have lived here for
decades, raising all 7 of their children in their modest
living quarters. Theirs is an impressive dynasty: 24
grandchildren, 19 great-grandchildren and 3 great-
great-grandchildren, with several more on the way. The
neighborhood around them is dotted with similar
small houses where many of her children and their
families live.
When a Human Rights Watch team visited Ramírez
on a warm Sunday in late August 2014, she was full of
energy. In the morning, she went to church, standing
through an hour-long service. Upon returning home,
she and her daughters prepared a big meal—it is tra-
dition for the family to come together on Sunday after-
noons. Even when most of the family sat down to eat,
she kept busy, making sure everyone else was getting
enough.
Her energy levels were remarkable for a woman
whose pancreatic cancer has metastasized to her
lungs and liver. Her condition was all the more notable
given how she had felt a few weeks earlier. Suffering
from severe abdominal pain and nausea, Ramírez had
no energy. She could not sleep and had lost her will to
live. Her daughter, Orlanda Hernández, said: “She did-
n’t want to eat. She would tell us that it hurt. She was
weak.  We didn’t see her improve.  She was frus-
trated…”
Ramírez attributes her remarkable turnaround to the
fact that she is now receiving palliative care at Mex-
ico’s National Cancer Institute. Before, she said, she
had complained about pain to her doctors, but she had
not received appropriate medications for it. In July 2014,
the local hospital in Hidalgo referred her to Mexico’s
National Cancer Institute; there physicians determined
that she had pancreatic cancer that was not treatable
16 Care When There Is No Cure
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Doña Remedios Ramírez Facio, 73, who has pancreatic cancer, 
at her home in Atitalaquia, Hidalgo, Mexico, on Aug. 31, 2014.
Doña Remedios and her daughter, Orlanda
Hernández Ramírez, 44, take a very early
morning journey to receive palliative care at the
National Cancer Institute in Mexico City, Mexico,
on Sept. 1, 2014. They left their home before 
5 a.m. and had to take multiple buses for a total
journey of 4–5 hours. 

and they referred her to the palliative care unit. The
physicians there assessed Ramírez’s pain and other
symptoms and put her on a small dose of morphine and
nausea medication.
The impact of this simple invention was drastic. As
Ramírez put it,
[With the pain] I didn’t have the desire to
do anything. I wasn’t hungry and didn’t
want to walk…nothing. I felt very tired and
didn’t have the urge to do anything so I
would lie down. I felt frustrated when
people spoke to me. It would anger me
when people spoke to me. [With palliative
care] I have come back to life.
But there is a complication. In all of the state of Hi-
dalgo, home to more than 2.5 million people, not a sin-
gle public hospital offers palliative care. Ramírez’s
daughter told Human Rights Watch that she had re-
cently taken her mother to the local hospital in Tula, the
closest town, because she was not feeling well; the
doctors there had no idea what palliative care was and
could not attend to her mother’s needs.
Thus, Ramírez has to travel to Mexico City every few
weeks to go to the National Cancer Institute, a trip that
takes almost the entire day. Luckily, she usually does
not have to go on public transport; the local community
clinic tries to make an ambulance available—for pay-
ment—to people who need to travel to hospitals in Mex-
ico City for medical care.
Even so, the trip to Mexico City is long. The ambu-
lance, which collects multiple patients and drops them
off at different hospitals all over Mexico City, picks up
Ramírez at around 4:30am so they can get to the hos-
pital in time for the appointment. The ambulance usu-
ally does not get her back home until around 4:30pm.
The round-trip cost –200 pesos (about US$15)–is more
than Ramírez and her husband normally spend in
weeks.
On September 1, Ramírez had an appointment at the
hospital, but the ambulance was not available. So she
and her daughter had to travel by public transport. They
left home shortly before 5am to walk 45 minutes
through the darkness to the closest bus stop. As her
daughter described the journey:
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Dr. Silvia Allende (back) and psychologist Leticia Ascencio speak with
Doña Remedios about her illness, her prognosis, and her symptoms at
the palliative care unit at Mexico’s National Cancer Institute.
To get to the cancer hospital, we need to
take a combi [a small bus]. Then we take a
bus that takes us to the bus depot. We
then get another bus that takes us to
Taxqueña. In Taxqueña, we get yet another
bus that takes us to the hospital. There are
four buses from here to there.
Even with help from the Human Rights Watch team,
which was filming Ramírez’s journey and took her part
of the way by car, the trip was arduous. Upon arriving
at the hospital, Ramírez said: “I get very tired travelling
all the way.”
On the day we accompanied her, Ramírez was in fairly
good health. As her illness progresses, however, her
condition is likely to deteriorate, making the trip—by
ambulance or public transport—increasingly difficult.
Indeed, many people with illnesses like Ramírez’s can
no longer make the journey at some point. In such
cases, the hospital recommends that relatives go by
themselves to pick up prescriptions and medicines. But
when the palliative care team is no longer able to speak
with and examine the patient, the care they are able to
provide is limited.
But on September 1, Ramírez made it to the hospital
and was able to benefit from the services it offered, and
meeting a physician, psychologist and nutritionist. The
physician extended her prescription for morphine and
added a medication for a cough that had started both-
ering Ramírez a few days earlier. The physician and psy-
chologist also spoke openly with Ramírez about her
illness and her prognosis—a tough conversation during
which she tearfully expressed her anxiety over leaving
behind her children, especially her son who, due to a
recent accident, is in a wheelchair.
No matter how difficult it was to face her own mortal-
ity, Ramírez left the hospital in an upbeat mood. She
said she felt grateful that the doctors had spoken with
her openly and with empathy: “It gives me more desire
to live.”
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Doña Remedios shows a doctor and a psychologist at the palliative care
unit at Mexico’s National Cancer Institute how much regular morphine
injections have reduced her pain. On the scale, her pain has gone from
“I can’t tolerate the pain” to “it hurts a little.” 
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Doña Remedios and her daughter at the pharmacy of the National Cancer Institute in Mexico City, Mexico on Sept. 1, 2014
to fill a prescription for morphine. They have to travel for several hours to procure the medication because there are no
hospitals with palliative care in Hidalgo, their home state.
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PEDRO PRECIADO SANTANA’S STORY
Pedro Preciado Santana, the 65-year-old owner of a
carpentry shop in Guadalajara, Mexico, was a viva-
cious man. He loved sitting on the porch outside his
home in the afternoons, waving and chatting with
friends and neighbors passing by, and watching the
park across the street. His daughter, Adriana Preciado
Pérez, said everybody in their neighborhood knew
him.34
In January 2010, an incapacitating pain in Preciado
Santana’s shoulder rudely interrupted this daily rou-
tine. His daughter told Human Rights Watch that, at
times, her father would turn completely white, his
blood pressure would drop and he would break out in
a sweat. Sometimes the pain was so severe that his
family would rush him to the emergency room.
Doctors struggled to determine what caused the dis-
comfort. After numerous fruitless visits to public and
private clinics, a neurosurgeon recommended surgery
in July 2010 for what he thought was a compressed ver-
tebra. However, the surgical intervention did nothing
to diminish the pain. In fact, that fall, Preciado San-
tana’s pain worsened and he repeatedly contracted
pneumonia.
Preciado Santana underwent more medical exams
and eventually his doctors found a malignant tumor in
his right lung. Despite the grim diagnosis, Preciado
Santana decided to fight. “My father loved life and he
wanted to do everything possible,” his daughter said.
“He didn’t choose to go. He was taken away from us.”
Two courses of chemotherapy and radiation at Centro
Medico Nacional de Occidente, a hospital of the Mex-
ican Social Security Institute (IMSS) where Preciado
Santana was insured, managed to reduce the size of
the tumor significantly, and his pain diminished as
well. But doctors thought that his immune system was
too compromised for him to undergo a third round of
chemotherapy and radiation; they told Preciado San-
tana that his case was terminal and that he had run out
of options.
Although he could no longer be cured, Preciado San-
tana’s healthcare needs were possibly greater than
ever before in his life. As the cancer grew, and spread,
Preciado Santana experienced ever more severe pain,
as well as various other symptoms. Due to emphy-
sema, a destructive process in the lungs, he was con-
A portrait of Don Pedro Preciado Santana graces 
the living room of the Preciado Santana family. 
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stantly gasping for air. Preciado Santana struggled emo-
tionally with his prognosis and became increasingly de-
pressed. These are all symptoms that can be controlled
well through palliative care.
Preciado Santana’s hospital, however, did not have a
palliative care service. As a result, he and his family had
to navigate their way through this very difficult period
with little or no professional guidance and very little
help from the hospital. Without anyone in his hospital
seeking to coordinate his case, the care he received was
highly fragmented, often inadequate, and required nu-
merous hospital visits even as travel became difficult
and painful. In fact, his last few months he and his fam-
ily struggled not only with his disease but also with the
very healthcare system that was supposed to care for
him.
For example, Preciado Santana’s daughter would take
him to the pain clinic at the hospital in his wheelchair
with his oxygen tank before 7:00 a.m. to take his place
in a cramped unventilated waiting room that tended to
be full of other patients, some of whom were acutely ill.
Sometimes, she said, her father would wait for six hours
before the doctor could finally see him. Moreover, only
one doctor at the hospital could renew his prescription
for morphine. On several occasions, Preciado Santana’s
daughter had to return at a later time or date to get the
prescription because that doctor had left for the day. 
Even in the advanced stages of his illness, when the
trip to the hospital had become very difficult because
of severe swelling, bed sores and skin problems, the
doctors at the pain clinic insisted that Preciado Santana
come in person. His daughter said: “When I told the
doctor that I could not take my father to the hospital
anymore, the doctor responded: ‘If you don’t bring him,
we won’t give him the medicines.’” With no other
choice, she continued to bring him to the hospital in
their private car. She said: “I would drive slowly. Any
bump, any pothole hurt him.”
When Preciado Santana’s daughter noticed that her
father was becoming increasingly introverted—he
stopped being his talkative self—and depressed, she
Adriana Preciado Pérez in her parents’ house, discussing her struggle
to ensure her father received proper care at the end of his life at a
public hospital. She eventually engaged a palliative care physician
from a private hospital to attend to him, allowing him to die
peacefully in his home. 
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requested a consult with a psychologist. However, the
psychology department could not schedule the ap-
pointment until four months later. By that time, Preci-
ado Santana was too ill and weak to be able to benefit
from the psychologist’s services.
As time went by, the severity of Preciado Santana’s
pain kept increasing and the morphine dosages that
doctors at the pain clinic prescribed became insuffi-
cient to control it. Yet, the doctors at the clinic were re-
luctant to increase the dose. His daughter told Human
Rights Watch: “They treated me as if I was trying to sell
the morphine; they were never able to control his pain.” 
Although the hospital had a home-based care service
for the chronically ill, this service was not adapted to
the needs of patients with limited life expectancy. When
Preciado Santana’s daughter inquired about enrolling
her father, she was told it could not take new patients
for a period of several months. An opening was eventu-
ally available, but it was too late; as Preciado Santana
had already died.
Disillusioned by the quality of the services provided
by the hospital, Preciado Santana’s daughter began
searching for other options to get proper care for her
dying father. In May 2011, the director of a private hos-
pice advised her to see Dr. Gloria Domínguez, who
leads an integrated palliative care team at Hospital Dr.
Ángel Leaño of the Autonomous University of Guadala-
jara. Her team accompanied Preciado Santana and his
family in the last few months of his life, visiting him at
his home and advising his daughter by telephone
whenever new symptoms or complications arose. Al-
though his daughter had to continue taking him to
some follow up appointments at Centro Medico for in-
surance reasons, the family could now rely on the pal-
liative care team in the day-to-day care of Preciado
Santana. 
The difference, his daughter said, was enormous. Dr.
Domínguez and her team attended to all her father’s
needs at once, providing medical treatment, psycho-
logical support and guiding the family in taking care of
him at home. By helping the family understand what
they could expect to happen as Preciado Santana drew
Adriana Preciado Pérez, 40, with her younger sister, Martha Elizabeth
Preciado Pérez, 30 and their mother, Guadalupe Teresa Pérez López, 69,
at their home in Guadalajara, Mexico on Aug. 30, 2014. The father of the
family, Don Pedro Preciado Santana, died of cancer in September 2011. 
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closer to his death and how they could respond, the
team also gave the family, in Adriana Preciado’s words,
“enormous peace of mind.”
Preciado Santana eventually passed away in Sep-
tember 2011 in his home, as had been his express wish.
Dr. Gloria Domínguez Castillejos, director of the palliative
care unit at Hospital Doctor Ángel Leaño, a private
hospital, in Guadalajara, Mexico on Aug. 29, 2014.
Domínguez cared for Don Pedro Preciado Santana during
his last few months. 
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33 This case study is based on interviews with Remedios Ramírez Facio and her daughter Orlanda, August 31 and
September 1, 2014, in Atitalaquia, Hidalgo, and Mexico City.
34 Human Rights Watch interview with Adriana Preciado Pérez, February 22, 2012, Guadalajara.
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II. The Experiences of People in Need of Palliative Care 
 
Almost 600,000 people die every year in Mexico, nearly half of them as a result of chronic 
illnesses such as heart and lung disease, diabetes, HIV or cancer.35 Hundreds of 
thousands more Mexicans battle with earlier stages of these and other chronic illnesses. 
Over the course of their illness many of these people experience debilitating symptoms 
such as pain, breathlessness, anxiety and depression. To ensure proper medical care for 
many of these individuals access to palliative care and pain medicines is essential. 
Without these services, they will suffer needless pain and distress undermining their 
quality of life and that of their families in their final days of life. 
 
Over the course of our research, we collected testimony from dozens of patients and their 
families about the challenges they faced accessing palliative care. While a few patients 
reported having access to comprehensive palliative care, the overwhelming majority of 
patients had no access to palliative care whatsoever or accessed care only with great 
difficulty, delays or with frequent disruptions. 
 
Availability of Palliative Care across Mexico 
Human Rights Watch estimates that many thousands of people in Mexico have no access 
to palliative care whatsoever as this service remains unavailable in most parts of the 
country, especially outside state capitals. A review of two recent studies of palliative care 
services and pain clinics, presented in Appendix 1, shows that seven of Mexico’s thirty-two 
states—Coahuila, Guerrero, Hidalgo, Quintana Roo, Sinaloa, Tlaxcala and Zacatecas—with 
a combined population of almost 16 million people do not have any known palliative care 
services in the public healthcare system; one of those states, Tlaxcala, does not have any 
hospitals with a pain clinic either.36 Another seventeen states have just one palliative care 
                                                          
35 Statistics from Instituto Nacional de Estadística y Geografía, 
http://www3.inegi.org.mx/sistemas/sisept/Default.aspx?t=mdemo107&s=est&c=23587 (accessed June 27, 2014). 
36 The National Health Council (Consejo Nacional de Salud) conducted one study; the Latin American Palliative Care 
Association the other. The Consejo Nacional de Salud sent a questionnaire to health authorities in all states requesting 
information on public hospitals that have pain clinics or palliative care units. All but two states—Chiapas and Puebla—
responded. The Consejo did not conduct follow-up verification of responses but noted to Human Rights Watch that the 
responses came from the official health authorities. The Latin American Palliative Care Association sought to identify all 
palliative care services in México through surveys of key informant interviews. The findings of the latter study can be found at: 
http://cuidadospaliativos.org/uploads/2012/10/atlas/15_México.pdf (accessed June 13, 2014). Some additional changes 
were made to the list based on new information. The table may not accurately reflect the availability of palliative care in 
hospitals that have integrated it into their services without creating a formal palliative care unit. These studies also did not 
survey primary health providers on whether they have integrated palliative care into their general care for patients. However, 
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service, in each case in the capital city. Just five of Mexico’s states—Guanajuato, Mexico 
State, Nuevo León, Tamaulipas, and Veracruz—have palliative care services and/or pain 
clinics available in multiple cities. The overview map shows the distribution of palliative 
care services and pain clinics around the country. 
 
Only in Mexico City do palliative care services exist in at least one hospital of each of 
Mexico’s three largest insurers, IMSS, ISSSTE, and Seguro Popular. Durango, Guanajuato 
and Jalisco are the only three states in which there are hospitals associated with these 
three insurers that have a palliative care service and/or pain clinic. Ten other states have a 
palliative care service or pain clinic in hospitals associated with two of these three 
insurance providers. As Mexico’s health insurers do not cross honor each other’s policies, 
even in states where palliative care is available in some hospitals, many people who need 
it may still not have access because they do not have the right insurance. 
 
As the overview map shows, the situation is particularly dire for people who live outside of 
state capitals. In both Chiapas and Jalisco, two of Mexico’s larger states, there are dozens 
of large and midsized towns that do not have any palliative care services or pain clinics. 
Our research found that in Chiapas, Jalisco and Nuevo León, palliative care was almost 
exclusively concentrated in capital cities (see Table 1). The state maps, see Section 
entitled “Accessing Strong Pain Medicines”, demonstrate visually how far people in 
communities all over these states must travel to access palliative care and pain treatment. 
By contrast, in Mexico State, where there are palliative care units in hospitals in seven 
different cities, the distances are significantly smaller. 
 
 
 
 
 
 
 
 
 
                                                                                                                                                                             
leading palliative care advocates in México who have done a lot of training of physicians believe the number of primary care 
providers that have done so to be very low. 
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Table 1 – Assessing Availability of Palliative Care in Chiapas, Jalisco and Nuevo León 
State Hospitals in 
public 
healthcare 
system37 
Number with 
palliative care 
service and/or pain 
clinic 
Number with pain 
clinic but no 
palliative care 
unit 
Chiapas 
» Tuxtla Gutiérrez 
» Rest of state 
59 
7 
52 
1 
1 
0 
1 
1 
0 
Jalisco 
» Guadalajara 
» Rest of state 
69 
22 
47 
4 
4 
0 
3 
3 
0 
Mexico State 
» Toluca 
» Rest of state 
114 
17 
97 
10 
4 
6 
0 
0 
0 
Nuevo León 
» Monterrey 
» Rest of state 
32 
16 
16 
2 
2 
0 
4 
2 
2 
 
Ximena Pérez’s Story 
Ximena Pérez was a 57-year-old mother and grandmother who lived with several of her 
children, grandchildren, and some animals in a home just outside of San Cristóbal de las 
Casas, a city in Chiapas.38 She worked in a bakery until she became ill in 2012. Pain in the 
right side of the stomach was the first sign that something was wrong. Pérez initially 
thought she had a bout of gastritis, but when the pain did not subside she decided to seek 
medical help. A local doctor examined her and discovered that she had a significantly 
enlarged gallbladder. A subsequent tomography found a tumor in her liver. 
 
The physician referred Pérez to a surgeon at a local general hospital to see whether the 
tumor could be removed. Her family scheduled an appointment. By the time of the 
appointment, Pérez’s pain had become very severe. She told a Human Rights Watch 
                                                          
37 We established the number of hospitals in each state using the ministry of health’s database of healthcare institutions 
(http://plataforma.salud.gob.mx:8091/), searching for “unidad de hospitalización” among the following institutions: IMSS, 
ISSSTE, Secretaría de la Defensa Nacional, Secretaría de Marina, Secretaría de Salud, and Universitario. 
38 Human Rights Watch interview with Ximena Pérez (pseudonym), San Cristóbal de las Casas, Chiapas, April 28, 2014. 
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researcher: “[It was there] the whole day, the whole day…In truth, I could not bear it 
anymore.” She added that she could no longer sleep for more than about a half hour at a 
time. 
When Pérez got to the hospital, an unpleasant surprise awaited her. The surgeon was not 
there so the appointment had to be rescheduled a full month later. Pérez told the hospital 
staff that she was in severe pain but only received pain medicines that are routinely sold 
over-the-counter in pharmacies and are not recommended for use for more than a few days 
because of its side effects. Pérez’s daughter said:  
 
My mom came [to the hospital] in a lot of pain but they didn’t pay 
attention…They only gave her ketorolac but that did not control the pain…I 
asked the doctor what my mom had…We were told to wait for the 
appointment with the oncologist…The appointment was canceled and 
another was scheduled for a month later…But my mother spent a lot of time 
in pain. 
 
Pérez herself said that “when I left [the hospital] I left crying because it hurt [so much].” 
 
The family learned about a pain clinic in Tuxtla Gutiérrez, the capital of Chiapas, but 
Pérez’s state of health was too bad for her to be able to make a trip that would take almost 
a full day. Family members told a Human Rights Watch researcher that they were at a loss 
as to what to do.  
 
A few weeks before our interview, a neighbor told the family about a primary care physician 
in San Cristóbal who was specializing in pain and palliative care. The family made an 
appointment with the doctor who examined her and prescribed opioid pain medicines. 
Pérez told Human Rights Watch: “I thank God for this doctor because with this [medicine] I 
can tolerate it.”  
 
In Search of Palliative Care 
Dozens of the patients we interviewed had managed to access palliative care at the time of 
the interview but said that they had faced significant delays—often months—in getting this 
care. In most of these cases, the hospitals where they sought care did not offer palliative 
care but did not refer them to providers that did. As a result, they struggled with symptoms 
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that were inadequately controlled until they eventually found a palliative care provider on 
their own. 
 
These people often described increasingly desperate searches for better care options and 
eventually, frequently through word-of-mouth and often very late in the illness, ended up 
with a palliative care program. For example, Guadalupe Herrera who has advanced 
diabetes described having significant neuropathic pain for over a year. She said that she 
has trouble putting on shoes because of a burning sensation in her feet: “It is as if 
someone is putting needles in my feet.” She told a Human Rights Watch researcher: 
 
I went back to the local clinic when weak pain medicines did not work. They 
told me the burning is because of diabetes. It's like they told me I would 
have to live like this [with the pain], that there was no remedy…The pain 
makes me feel depressed. My state of mind is much affected by the pain. 
I'm a big cry baby but sometimes it hurts so much.39 
 
There are manifold reasons for these kinds of delays in the provision of palliative care: 
physicians may feel that they are able to provide adequate care themselves despite not 
having any training in palliative care; they may be reluctant to refer patients to other 
departments at their hospital or to other institutions; the absence of referral protocols and 
information about hospitals that have palliative care complicates referrals as do the lack 
of cross-honoring of health insurance and the absence of any palliative care services at 
any nearby hospital. 
 
The situation at a specialized pain and palliative care institution in the Zapopan area of 
Guadalajara offers a particularly vivid example of how the lack of a referral system and late 
referrals lead to unnecessary suffering. Instituto Jalisciense de Alivio al Dolor y Cuidados 
Paliativos (Instituto Palia) is an institution of the Jalisco state government that offers pain 
management and palliative care to patients irrespective of their insurance status. It has 
several multidisciplinary teams that visit patients in the metropolitan area of Guadalajara 
in their homes to provide them palliative care. It is a unique institution in Mexico that 
offers a service—full-fledged home-based care by a team consisting of a physician, nurse, 
social worker and psychologist—that few other institutions in the country can match. 
                                                          
39 Human Rights Watch interview with Guadalupe Herrera (pseudonym), Guadalajara. 
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Yet, according to Instituto Palia’s staff, fewer than 50 percent of its patients come via 
referral by doctors at other institutions. While the institute does not collect data on referral 
sources, all physicians at the institution we interviewed lamented the fact that so few 
doctors at other hospitals referred patients directly to them—or did so very late—despite 
not having the capacity to care for the patients properly themselves. Dr. Rosa Margarita 
Álvarez, one of those physicians, commented: “The majority of our patients are referred by 
other patients or someone else [not doctors]. Eighty percent come with pain that has not 
been treated properly.”40 Dr. Karla Madrigal, another physician at the institute, told Human 
Rights Watch:  
 
Very frequently patients are referred late. Often, people come to us on their 
death bed. When you go [to their homes] the next day the patient is already 
dead. They are sent at the very end…They [the relatives] are desperate, 
someone tells them about us... 41 
 
María García’s Story 
When we interviewed María García, a woman of around 70, she lived in a modest home in 
San Juan de los Lagos, a small town in Jalisco, with her husband, youngest daughter and 
baby grandchild.42 She had been completely bedridden for two years as the result of a 
metastatic tumor in her back that had left her paralyzed. 
 
She had become ill a few years earlier when she developed pain in her leg, which later 
extended to her spine. She tolerated the pain for some time but eventually went to the 
doctor who discovered tumors in her back and leg. García underwent surgery to amputate 
part of one leg and remove the tumor in her back. The operation caused damage to the 
nerves in her spinal cord, which left her unable to walk. 
 
García had a series of health needs, ranging from increasingly severe pain to skin care—
people who are bedridden often develop bed sores—to psychosocial care. While María had 
insurance through Seguro Popular, the local hospital in San Juan de los Lagos did not offer 
palliative care. Her doctor prescribed analgesics but they were not strong enough to 
                                                          
40 Human Rights Watch interview with Dr. Rosa Margarita Álvarez, November 14, 2011, Guadalajara. 
41 Human Rights Watch interview with Dr. Karla Madrigal, November 14, 2011, Guadalajara. 
42 Human Rights Watch interview with Maria García (pseudonym), February 25, 2012, San Juan de los Lagos, Jalisco. 
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control her pain. García needed morphine or another opioid pain medicine but San Juan de 
los Lagos did not have physicians who prescribe these or pharmacies that sell them. 
García told Human Rights Watch researchers that her pain was very severe. She said:  
 
I almost faint. I feel like it’s going to give me a heart attack…It’s like 
electrical charges from where I have the prosthesis. I have shocks that go 
up and down. I scream, I cry. I don’t know what I do. 
 
Unable to get proper care locally, García’s family took her to Aguascalientes and 
Guadalajara, a difficult one-and-a-half hour journey for a woman who is paralyzed and in 
severe pain. A hospital in Guadalajara provided García with a morphine infusion pump that 
helped her control her pain. 
 
By the time we interviewed her, however, García was no longer able to travel to 
Guadalajara for check-ups. Her aging husband had to travel once a month to the hospital 
there in order to buy a new supply of morphine, which is not covered under Seguro Popular. 
The palliative care team at the hospital in Guadalajara had to manage García long distance 
and make adjustments to her treatment without being able to examine her. 
 
The Hardship of Travel 
We encountered this scenario repeatedly in our interviews, of people with terminal 
illnesses—and often in rapidly deteriorating condition—traveling long distances, 
sometimes as long as six to eight hours on a bus, in order to receive palliative care or 
receiving it remotely. With no hospital close to home offering palliative care—or no system 
to refer patients to hospitals that do—these people faced the unenviable choice between 
traveling long distances, often on rickety buses, in order to access palliative care or asking 
relatives to do the traveling for prescriptions and receiving suboptimal care. 
 
This scenario is very common for the simple reason that diagnosis and curative treatment 
for life-limiting illnesses is often available only at tertiary care institutions. As primary care 
physicians do not have the equipment or knowledge to treat cancer or heart disease, for 
example, they generally refer patients to secondary care institutions as soon as they 
suspect a serious condition. In many cases, that process repeats itself at the secondary 
care level and patients are referred to a specialist hospital. With each referral the distance 
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patients must travel to access treatment increases, as specialized hospitals tend to be 
located only in major metropolitan areas. 
 
For curative care, the cost and inconvenience of such travel may be unavoidable as primary 
and many secondary care facilities do not have the specialists, diagnostic equipment, 
laboratory capacity, and treatment options available to properly manage patients with 
complex illnesses. This is not true, however, for palliative care, which for most patients 
does not require any complex interventions and can be provided at lower levels of care. 
Moreover, as we have seen in several of the testimonies above, for people with terminal 
illness travel is extremely difficult, making it all the more important that palliative care be 
available close to or in the home. 
 
When people who are terminally ill can only access palliative care by travelling long 
distances to tertiary care hospitals the central objective of this care—safeguarding the 
dignity of these people—is not achieved. Mexican legislators were clearly mindful of that 
fact when they adopted the amendments to the health law and explicitly included a right to 
receive palliative care in the home. Yet, palliative care services have not been 
decentralized sufficiently to allow people to receive it in or close to their homes. 
 
We encountered this scenario over and over again when at Mexico’s National Cancer 
Institute (NCI) in Mexico City. We interviewed multiple patients who were in their last 
weeks of life and arrived at the hospital in a terrible state after traveling for hours on buses. 
In some cases, relatives carried their loved ones wrapped in blankets from the bus or taxi 
to the hospital because the patient could no longer walk or stand. We also interviewed 
numerous relatives of patients who were no longer able to make the trip to the NCI. In such 
cases, the palliative care team had to adjust treatment decisions based on descriptions by 
relatives rather than on examination of the patient. Often, the care offered was reduced to 
just renewing prescriptions. Better than being left without care but far from the quality of 
care patients should receive.  
 
In 2012, the palliative care service at the NCI conducted a review of the cases of 600 
incurable cancer patients attended in 2010, many of whom had lived outside Mexico City. 
The review found that almost 30 percent of patients attended the service only once, even 
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though all were given a follow-up appointment.43 While the study did not establish the 
reasons why patients did not return, the NCI’s doctors believed that a significant 
proportion were unable to return because they were too ill to travel or lacked the financial 
resources to do so.44 
 
Accessing Strong Pain Medicines 
 
“[I have a pain all the time but] when food goes into my colon I cannot 
tolerate the pain. It is like a bomb…In the hospital, I was told to endure the 
pain.” – Liliana Arroyo, a patient with colon cancer45  
 
Pain treatment is a critical component of palliative care and our research specifically 
examined the availability and accessibility of strong analgesic medicines. Although strong 
analgesic medicines like morphine are relatively inexpensive, we found that these 
medicines are often difficult to access because few physicians are trained in using them 
and because they are controlled substances and thus subject to special regulations.  
 
The experiences of people we interviewed point to a gaping divide between the availability 
of pain medicines for people who live in major metropolitan areas or state capitals and 
those who live in smaller towns and rural areas. For the latter, accessing opioid analgesics 
is enormously difficult because very few doctors outside of state capitals seek licenses to 
prescribe them and almost no pharmacies sell these medicines. People in state capitals 
generally had better access to doctors able to prescribe these medicines but frequently 
encountered difficulties filling prescriptions because of strict rules and shortages of 
medicines. 
 
The government has announced steps to try to resolve many of the problems our research 
identified. For discussion, see Chapter V. 
 
 
                                                          
43 Allende-Perez, S., Mohar A., De La Garza J., Herrera A., Meneses A., Verástegui E., “Care for All: Palliative Care Strategy to 
Provide Intensive Acute Symptom Control Management for Patients with Previously Undiagnosed Terminal Cancer at the 
Instituto Nacional de Cancerología in México City,” Journal of Palliative Care and Medicine. In press. 
44 Ibid. 
45 Human Rights Watch interview with Liliana Arroyo (pseudonym), November 12, 2011, Guadalajara. 
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Outside Major Metropolitan Areas: Lack of Licensed Prescribers and Pharmacies 
There is an alarming lack of doctors who obtain licenses to prescribe opioid analgesics 
and pharmacies that dispense them in much of Mexico. While in major cities, such as state 
capitals, there generally are some doctors with such licenses in pain clinics or palliative 
care units at major hospitals, outside the major cities it is often impossible to find doctors 
licensed to prescribe these medicines or pharmacies that dispense them. Patients who live 
there face the unenviable choice between traveling long distances to access treatment—
often while in pain—or suffering without it. The reasons for the shortage of prescribers of 
these medicines, which are related to insufficient training of physicians in pain 
management and complicated bureaucratic requirements to be able to prescribe, are 
described in Chapter III. 
 
As part of our research in the states of Chiapas, Jalisco, and Nuevo León we sought to 
identify all physicians who prescribe opioid analgesics to patients with chronic pain and 
all pharmacies that dispense these medicines. While there are multiple prescribers and 
pharmacies in the capital cities of all three states, there are almost none in the rest of 
these states. In Jalisco, for example, there are 14 municipalities with populations over 
50,000 people. Just three of them have physicians who prescribe opioid analgesics for 
chronic pain and only one—Puerto Vallarta—also has a pharmacy that sells them. In 
Chiapas, two of the 22 municipalities with populations over 50,000 people outside of 
Tuxtla Gutiérrez—San Cristóbal de las Casas and Tapachula—have physicians that 
prescribe these medicines but only Tapachula has a pharmacy that sells them. None of 
Nuevo León’s three municipalities of more than 50,000 people outside the metropolitan 
area of Monterrey have physicians that prescribe opioids for chronic pain or pharmacies 
that sell the medicines. The state maps offer a visual representation of the situation in 
these states. 
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A publication by Raymundo Escutia, a pharmacist in Guadalajara, shows a similar dynamic 
in other states. His research found that in 2011 three states did not have a single pharmacy 
that sold oral morphine; in another 16 states, there were no such pharmacies outside the 
state capital.46 
 
As a result, people with pain from outside the major metropolitan areas often have to 
travel all the way to their state capitals in order to obtain or fill prescriptions for strong 
pain medicines. For many, such travel is an insurmountable barrier as they or their families 
either do not have the ability—financially or physically—to travel long distances or because 
their physicians do not refer them to colleagues able to prescribe opioid analgesics. 
 
Dr. Araceli García Pérez, the only physician in Ciudad Guzman, Jalisco, who prescribes 
opioid analgesics for chronic pain, described the challenges for her patients as follows: 
 
[Most of my] patients are unfortunately of low resources. Many have never 
been to Guadalajara. [It is a challenge for them] to find the Farmacias 
Especializadas where [morphine] is sold...Those with money…drive over to 
buy the medications but most patients have little means and a limited 
cultural level. For poor patients [it means] spending more money on the trip, 
without knowing Guadalajara...So it becomes something impossible for 
them to do.47  
 
She noted that these patients will pay more to travel to Guadalajara than for the 
medications. 
 
Dr. Juan José Lastra, a general practitioner licensed to prescribe opioid analgesics, has a 
practice in Ajijic, a community outside Guadalajara with a large number of retired 
foreigners, mostly from the United States and Canada. He said: 
 
If you tell the patient or the family: “Here’s the prescription, go and buy it,” 
the patient is going say that he needs it right now. They say: “It’s going to 
                                                          
46 Raymundo Escutia et al., “Guía Practica del uso Racional de Analgésicos Opioides,” 2011, http://www.ofil-
internacional.org/uploads/documentos/Gu%C3%ADa%20pr%C3%A1ctica%20del%20uso%20Racional%20de%20Analg%C
3%A9sicos%20Opioides%20Raymundo%20Escutia%20%202011.pdf (accessed June 27, 2014). 
47 Human Rights Watch interview with Dr. Araceli García érez, November 13, 2011, Ciudad Guzman, Jalisco. 
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take me 1 hour to get to Guadalajara, half an hour in traffic, then back – it’s 
going to take me three hours.”48 
 
Dr. Carlos García, also a general practitioner in Ajijic said: “The majority of my patients are 
old. They mostly have serious health conditions, such as cancer. The patient generally 
can’t go so a family member has to make the trip.”49 
 
The lack of physicians that get licensed to prescribe opioid analgesics and the lack of 
pharmacies that sell them create a vicious cycle that perpetuates this untenable situation. 
Medical doctors do not prescribe opioid analgesics because of the hassle of obtaining 
prescription rights. Pharmacies do not stock the medicines because there are no 
physicians who prescribe them. This, in turn, becomes an additional disincentive for 
doctors to obtain prescription rights: Why should they do all the work to be able to 
prescribe these medicines when patients cannot fill the prescriptions locally anyway? 
 
Accessing Pain Treatment in Urban Settings 
While the situation in state capitals is significantly better than outside, there is a shortage 
of physicians licensed to prescribe opioid analgesics and pharmacies that sell them even 
there. In many places, only doctors at pain clinics at tertiary level hospitals have 
prescription rights, meaning people can only get these medicines if they are referred to 
those clinics. Furthermore, even in state capitals, the numbers of pharmacies that sell 
opioid analgesics is very low. In the metropolitan area of Guadalajara, a city of about five 
million people, just fifteen pharmacies stock these medicines.50 In Tuxtla Gutiérrez, a city 
with a population of half a million people, just three pharmacies stock them. 
 
This means that patients often have to travel significant distances within these cities in 
order to get to the doctors’ offices that prescribe these medicines and to pharmacies that 
can fill prescriptions. Sofía González, for example, a chronic pain patient in Guadalajara, 
told a Human Rights Watch researcher: “I have to go to a pharmacy that has controlled 
medicines...None of these pharmacies are nearby. I usually leave in the morning and have 
to take two buses. It takes two or three hours. Sometimes I can't fill the prescription. I call 
                                                          
48 Human Rights Watch interview with Dr. Juan José Lastra, November 11, 2011, Chapala, Jalisco. 
49 Human Rights Watch interview with Dr. Carlos García, November 11, 2011, Chapala, Jalisco. 
50 Email correspondence with Alan Ruiz, pharmacist at Instituto Palia in Guadalajara, June 27, 2014. 
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and they tell me whether they have it. Sometimes they don't...I try to talk to them before 
[my medicines] finish. When I have few drops left, I talk [to them]. I don't want to end up 
without...”51 
 
Challenges Due to Strict Prescription and Dispensing Rules and Stock-Outs 
Even when people are able to obtain a prescription for an opioid analgesic and access a 
pharmacy that sells these medicines, they may still face challenges getting their medicines: 
Mexico’s inflexible regulations for prescriptions of opioid analgesics and unreliable supply 
often lead to pharmacies being unable to fill prescriptions for these medicines. Some 
doctors we interviewed estimated that pharmacies cannot fill up to 15 percent of their 
prescriptions for opioid analgesics (see below, Chapter III) because of current prescribing 
rules. For patients, the result can be being left without adequate pain medicines and 
spending hours traveling back to the doctor and then returning to the pharmacy. 
 
For example, José Luis Ramírez, a man with a large throat tumor from Guadalajara, told a 
Human Rights Watch researcher that he had to return to the hospital when the pharmacy 
did not have the name of the medication indicated in the prescription, even though the 
same medication from a different pharmaceutical company was available:  
 
There is one that is called Analfin [morphine] and they [only] have it with a 
different name. And because of that they don’t give it to you. You have to go 
back to Palia [the hospital] so that they put it [the right name]. Otherwise 
they can’t sell it to you.52 
 
A one-way trip to the hospital takes Ramírez an hour-and-a-half on public transport. 
 
The brother of Esmeralda Márquez, an 82-year-old patient with chronic pain, said that on 
various occasions pharmacies could not fill prescriptions: 
 
If you have a prescription for 15mg but they don't have them, they can't sell 
[other strengths]. I have to talk to the doctor and return to Palia [the 
                                                          
51 Human Rights Watch interview with Sofía González (pseudonym), November 15, 2011, Guadalajara. 
52 Human Rights Watch interview with José Luis Ramírez (pseudonym), February 28, 2012, Guadalajara.  
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hospital] to get a new prescription. It’s controlled [strictly]. I told her [my 
sister]: You know, it would be easier to buy marijuana.53 
 
Describing her desperation when her relatives were unable to fill her prescription, Daniela 
Moreno, a chronic pain patient in her eighties, said: 
 
The day I don’t have the tablet, I feel desperate…I feel in the night, oh, I 
can’t sleep. The eight days that they couldn’t find it…one day I put water in 
the bottle that had contained the tablets [and drank it] to see if it would 
stop the pain…It was desperation.54 
 
Reluctance to Prescribe Opioids: A Specialist’s Task? 
Throughout our research, both primary care physicians and oncologists interviewed 
repeatedly told us that they do not prescribe opioids because they see it as a pain 
specialist’s job. These doctors often said they either prescribe weak pain medicines, 
sometimes even when pain is moderate to severe, or refer patients to a pain clinic. 
 
Testimony from an oncologist who works in Tuxtla Gutiérrez and Tapachula in Chiapas was 
typical. The oncologist said that he had never sought a license to prescribe opioid 
analgesics even though he said it would not be hard to get. He said that he sends private 
patients to a palliative care expert in Tuxtla Gutiérrez and patients with pain at his public 
hospital in Tapachula to the pain clinic. The oncologist said that even though he routinely 
has patients with moderate to severe pain he does not have the “profile” to prescribe 
opioids and that he “prefers that they are managed by an expert.”55  
 
Dr. Araceli García Pérez from Ciudad Guzman, the only physician licensed to prescribe 
opioid analgesics in her city of about 100,000 people, said: 
 
Normally patients have to go to a pain doctor because general practitioners 
are not trained for this kind of situation. They therefore prefer not to get 
involved in this stuff. It is a pain having to ask for prescription forms 
                                                          
53 Human Rights Watch interview with Esmeralda and Miguel Márquez (pseudonyms), November 12, 2011, Guadalajara. 
54 Human Rights Watch interview with Daniela Moreno (pseudonym), November 10, 2011, Guadalajara. 
55 Human Rights Watch interview with José Escobar (pseudonym), April 25, 2012, Tuxtla-Gutiérrez, Chiapas. 
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etcetera when you don’t really know how to manage these things 
[prescribing of opioids].56 
 
For patients, however, this often means adding extra steps, requesting additional 
appointments with the pain clinic and making extra trips to the hospital. It also appears to 
result in the overprescribing of weak pain medicines by physicians who do not prescribe 
opioids but delay referring their patients to pain or palliative care specialists. A number of 
palliative care or pain physicians complained that their colleagues’ lack of knowledge 
about pain management led to the excessive use of over-the-counter pain medicines 
which, when used over extended periods of time, can do serious and irreversible damage 
to the gastrointestinal tract and the kidneys. Dr. Jesús Medina, a physician at Instituto 
Palia, described a situation he and his colleagues commonly see: 
 
Patients come in very advanced stages. They've been on non-opioids pain 
medicines for years. The doctors have already screwed up their stomachs. 
They already have renal problems due to high use of non-steroidal anti-
inflammatory drugs (NSAIDs)…The NSAIDs are much more dangerous than 
the opioids. Side effects of narcotics can be managed. We have geriatric 
patients who have been using NSAIDs daily for 11 to 14 months. Of course 
they already have intense gastrointestinal problems. They are nutritionally 
compromised as they are not eating because it hurts to eat.57 
 
Dr. Araceli García Pérez from Ciudad Guzman concurred: 
 
Sometimes surgeons, gynecologists, oncologists have patients who are 
terminal that should be in palliative care…Oncologists don't know how to 
treat patients with pain. I’ve seen patients [in moderate to severe pain] that 
they [the oncologists] continue to give paracetamol, paracetamol and 
paracetamol. I tell them why? They say it's the only thing. The patients are 
already almost in death throes…and they still continue to give them 
paracetamol. They [the doctors] panic at the thought of morphine.58 
                                                          
56 Human Rights Watch interview with Dr. Araceli García Pérez, November 11, 2011, Ciudad Guzman, Jalisco. 
57 Human Rights Watch interview with Dr. Jesús Medina, November 16, 2011, Guadalajara. 
58 Human Rights Watch interview with Dr. Araceli García Pérez, November 13, 2011, Ciudad Guzman, Jalisco. 
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A patient who was receiving 50 mg of morphine per day told us that her oncologist 
recommended that she immediately stop taking morphine after she had a colectomy.59 The 
oncologist apparently did not realize that this would have caused her patient to go into 
withdrawal. Luckily for the patient, she consulted her doctor at Instituto Palia before 
following the oncologist’s recommendation. Dr. Jesús Medina, the physician who treated 
her at Instituto Palia, told Human Rights Watch he encounters stories like that on a regular 
basis.60 
 
Access to Palliative Care for Children 
Antonio Méndez’s Story 
Antonio Méndez, the youngest child in a middle-class family in Tepatitlán de Morelos, a 
town of about 100,000 inhabitants in the state of Jalisco, was almost six when his parents 
noticed that he had a significantly swollen ganglion in his neck in 2008.61 Thinking it was 
an ordinary infection, a local doctor prescribed antibiotics. However, neither this nor a 
second course of antibiotics succeeded in bringing down the swelling. Although Antonio 
was eating well, his parents said that he also inexplicably began to lose weight. Concerned 
about his health, they took him to a hospital in Guadalajara for a biopsy. The results came 
back positive for a rare form of cancer called rhabdomyosarcoma, a malignant tumor of the 
muscles. 
 
When Human Rights Watch researchers visited him in February 2012, Antonio was nine and 
had been receiving chemo and radiation therapy for three-and-a-half years at a hospital in 
Guadalajara, about 50 miles from his home. His prognosis was bleak: he had metastases 
in his head and in his lungs. At the time, Antonio had a visible tumor in his neck and his 
eye had recently become swollen as well. We decided not to interview him because he was 
experiencing significant discomfort, but we spoke to his parents. 
 
Antonio’s parents knew that their son’s cancer had become incurable and they were ready 
to accept the fact that he was going to die. They had grown increasingly wary about 
continuing with chemotherapy and the impact its side effects had on Antonio. As his 
mother told us: 
                                                          
59 Human Rights Watch interview with Beatriz Álvaro (pseudonym), November 15, 2011, Guadalajara. 
60 Human Rights Watch interview with Dr. Jesús Medina, November 16, 2011, Guadalajara. 
61 Human Rights Watch interview with the parents of Antonio Méndez (pseudonym), February 24, 2012, Tepatitlán, Jalisco. 
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Antonio has been getting chemo for three years. [He had] only a single three 
month [break] because he was getting radiation therapy…[T]he 
consequences of the chemo have been many: hemorrhage, constipation, 
nausea, throwing up everything, low immune system, low platelet count, 
meningitis infection...This month, the chemo burnt a little vein here. The 
chemo has so many consequences… 
 
While the family was ready to embrace treatment focused on Antonio’s quality of life rather 
than on cure, the hospital did not have a palliative care unit or staff trained in palliative 
care. None of the doctors at the hospital had discussed the option of palliative care with 
them despite the fact that Antonio was a likely candidate for palliation and that 
Guadalajara, where he was receiving treatment, has multiple hospitals that offer palliative 
care, including for children. Instead of offering palliative care, Antonio’s oncologist 
convinced his parents to continue with more chemotherapy. Antonio’s mother told us: 
 
When I was told a year ago that the cancer had infiltrated, I said: “We’re not 
going to give him any more chemo.” But the doctor said: “If you don’t give 
him chemo, it [death] is going to happen sooner.” 
 
Given no other option, Antonio’s parents agreed to continue with chemotherapy despite 
their misgivings. 
 
When we met with them, Antonio’s parents had no idea what palliative care was, even 
though it coincided almost exactly with the wishes they had for their son’s care. 
Unfortunately, they said, it was very difficult to discuss their priorities for their son’s care 
with the oncologist. Although Antonio’s mother thought the doctor was very competent, 
she was not willing to engage in discussions of their son’s care. His mother said:  
 
Antonio’s oncologist is of few words. She gives you the diagnosis but she 
never explains anything. Never, ever. And she doesn’t like you asking. If 
you keep asking, she stops you, kind of “that’s enough.” 
 
Antonio’s father added: “Don’t even ask because she’s very sensitive.” 
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In December 2011, Antonio developed severe pain. His mother said that he would cry a lot 
and grab his head. The oncologist referred him to the hospital’s pain clinic where a doctor 
prescribed morphine. However, the doctor had instructed Antonio’s parents to give him a 
quarter tablet of morphine in the morning and another in the evening. If he suffered from a 
lot of pain the doctor told them to give him three or four doses per day. These instructions 
were inconsistent with recommendations from the WHO on cancer pain treatment, which 
stipulate that patients should receive morphine every four hours to ensure continuous 
pain relief.62 As a result, Antonio continued to be in pain during much of the day. 
Eventually, his mother decided herself to start giving him morphine every four hours when 
he was in a lot of pain. 
 
The doctors at the pain clinic also failed to provide Antonio’s parents with adequate 
information on the side effects of morphine. His mother said that they “have never really 
talked to me about it or anything.” As a result, Antonio suffered from constipation and 
nausea without appropriate treatment. She said:  
 
When I gave it [morphine] to him for the first time…his stomach would hurt 20 
minutes later. What is the point on of taking pain away from him if we cause 
another [symptom]…?” We had to go all the way [to Guadalajara] to ask. 
 
Antonio’s mother also said she was concerned—unnecessarily—that if her son received 
morphine now it might stop working when his pain would get even worse: “I told myself: 
‘Well, I’ll give it to him more often,’ but at the same time I thought: ‘If I give it to him more 
often, when he experiences this strong pain it’s not going to work on him.’” 
Their son’s illness had created enormous stress and anxiety within the family, something 
that a palliative care team could have helped resolve. Antonio’s mother, for example, 
described a near breakdown she had suffered a week before our visit in February 2012: 
 
Last week I felt so bad when I saw Antonio’s eye [swollen] like that. I have 
lived through the disease with Antonio for three years…and he has been 
severely ill... Still, [it was the first time] that I said: “No, it’s my husband’s 
                                                          
62 WHO, “WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses,” 2012, 
http://whqlibdoc.who.int/publications/2012/9789241548120_Guidelines.pdf, p. 48-49. (accessed on July 14, 2014). 
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turn now, I don’t want to see anymore.” And at the same time I said: “What 
if my son sees that his mother isn’t present anymore,” so then I stayed. But 
yes, emotionally I was about to quit last week. 
 
Weighing most heavily on Antonio’s parents was the lack of information about what was 
going to come as their son deteriorated and about how they should care for him. They were 
in charge of caring for a child who was dying and nobody had told them or him what to 
expect and how to manage. When Human Rights Watch staff offered to put the family in 
touch with a pediatrician in Guadalajara who was specialized in pediatric palliative care, 
one of Antonio’s mother’s first questions was: “His oncologist, she hasn’t talked to me 
honestly about what can happen. Can she [the palliative care physician] talk to me openly 
about that?” 
 
The pediatric palliative care physician, Dr. Yuriko Nakashima, cared for Antonio during his 
last few months, controlling his pain and other symptoms and assisting him and his 
parents between home visits by phone and video. Antonio eventually died peacefully in 
May 2012. 
 
The Lack of Palliative Care Services for Children 
The WHO defines children’s palliative care as “the active total care of the child’s body, 
mind and spirit,” as well as support for the family.63 Children’s palliative care includes 
efforts to assess and treat pain; the provision of medicines in appropriate formulations for 
children; support for the child through play, education, counseling and other methods; 
child-appropriate communication about the illness; and communication with, and support 
for, the family.64 It should also address child protection, as some severely ill children are 
vulnerable to exploitation, abuse and neglect.65 Hence, palliative care for children requires 
pediatric expertise, including on child-specific symptoms and diseases, as well as 
expertise in child psychology and child protection. 
 
                                                          
63 WHO, National Cancer Control Programs: Policies and Managerial Guidelines, 2002, p. 85, 
http://www.who.int/cancer/media/en/408.pdf (accessed February 12, 2010). See also Justin Amery, ed., Children’s 
Palliative Care in Africa (New York: Oxford University Press, 2009).  
64 WHO, National Cancer Control Programs: Policies and Managerial Guidelines, 
http://www.who.int/cancer/media/en/408.pdf, p. 85. See also Amery, Children’s Palliative Care in Africa.  
65 Amery et al., “The Beginning of Children’s Palliative Care in Africa,” Journal of Palliative Medicine 12 (2009): 1015-21, 
accessed June 27, 2014, doi: 10.1089/jpm.2009.0125.  
  51 HUMAN RIGHTS WATCH | OCTOBER 2014 
Palliative care is very important for children with life-limiting illness. For children, serious 
illness, pain, hospitalization, and invasive medical procedures are often profoundly 
disorienting and traumatizing and can cause great suffering. For parents and caregivers, 
watching a child suffer from symptoms and medical procedures, balancing the needs of 
the sick child with those of other children, and facing the prospect of potentially the 
child’s death, cause great distress. Pediatric palliative care can help both children and 
parents navigate these difficult circumstances by relieving distressing physical symptoms, 
minimizing pain due to medical procedures, and enhancing communication among health 
care workers, children and parents about the child’s illness and prognosis. 
 
Thousands of children in Mexico need palliative care annually, including more than 1500 
children who die of cancer each year. Doctors at the palliative care unit of the National 
Pediatrics Institute (NPI) in Mexico City, the largest children’s hospital in the country, 
estimate that about 40 percent of all children attended at this tertiary care hospital have 
life-limiting illnesses and potentially require palliative care.66 A study of more than a 
thousand children attended by the palliative care unit of the NPI found that about 38 
percent of patients had cancer; almost 30 percent had severe neurological conditions, 
such as epilepsy, encephalopathy, and hydrocephaly; and the rest a variety of other 
conditions.67 A review of symptoms of a sample of these patients showed that 70 percent 
suffered from bronchial or oropharyngeal secretions (wet secretions from the mouth or 
throat that cause an unpleasant rattling sound) and 67 percent suffered from pain.68 
 
As with adults, very few hospitals offer pediatric palliative care, meaning that this health 
service is inaccessible to many families who require it. Children are even worse off as only 
six hospitals in all of Mexico—the National Pediatric Institute, Hospital General Dr. Manuel 
Gea González in Mexico City, the Hospital Civil de Guadalajara, Hospital del Niño in Toluca, 
Hospital del Niño in Morelos and Hospital Infantil Teletón de Oncología, a charitable 
hospital—are known to have specialized pediatric palliative care teams. The remainder of 
the more than forty hospitals in Mexico that attend to children with cancer and other 
advanced diseases do not have known palliative care services. 
 
                                                          
66 Garduño et al, “Cuidados Paliativos en Pediatría. Experiencia en 1121 Niños del Instituto Nacional de Pediatría de México,” 
Draft article. On file with Human Rights Watch. 
67 Ibid. 
68 Ibid. 
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The pediatric specialty hospital in Tuxtla Gutiérrez, Hospital de Especialidades Pediátricas, 
is one example. This hospital, which opened in 2006, offers comprehensive secondary 
level health services for children in Chiapas, including treatment for cancer and other life-
limiting illnesses. It is the only such hospital in the state. The hospital’s oncology 
department sees about 60 children with cancer per year.69 According to oncologists at the 
hospital, only about 20 percent of these children survive.70 
 
Yet, the hospital does not have a palliative care unit, anyone on staff with palliative care 
training, or any physician licensed to prescribe strong opioid medicines for chronic pain. 
Children who become incurable are sent home and told to come back every two weeks for 
follow-up appointments. Patients who require pain management are sent to the regional 
hospital, which has a pain clinic but no staff trained specifically in pediatric pain 
management. The hospital has no call service to support parents of children who are dying 
at home. When a child has complications or a spike in pain they have no other option but 
to go to the emergency room of the hospital. For many patients, however, this trip can take 
many hours. 
 
Oncologists at the hospital lamented not being able to offer palliative care. One told 
Human Rights Watch: 
 
I think palliative care is very important because many patients feel that you 
are not going to attend to their needs anymore, that you are abandoning 
them. If we had palliative medicines, we could continue to have support of 
the hospital.71 
 
                                                          
69 Interview with director and oncologists at Hospital de Especialidades Pediátricas, Tuxtla Gutiérrez, Chiapas, April 23, 2012. 
70 Ibid. 
71 Ibid. 
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Two Pediatric Palliative Care Models: Morelos and Mexico State 
The experiences of two public children’s hospitals in central Mexico we visited 
demonstrate how a relatively limited investment in palliative care, paired with strong 
leadership, can achieve significant results in improving the care for children with 
incurable or terminal illness. The two hospitals—the Hospital del Niño in Toluca, 
Mexico State and the Hospital del Niño in Cuernavaca, Morelos—each set up 
palliative care programs in 2013.72 
  
Both hospitals use broadly similar models to provide palliative care. Each has at 
least one full-time staff member dedicated exclusively to palliative care that 
coordinates the care of patients. Both hospitals have home-based care services and 
offer round-the-clock support to patients and parents via telephone and/or text 
message. The administrations of both hospitals have also designated physical 
space—in Cuernavaca, a procedure room, in Toluca, a small office—to the palliative 
care service. 
  
In both hospitals, the decision to refer a child to palliative care is taken by the 
treating physician, usually when curative treatment is discontinued. Following such 
referral, the physician works with the multidisciplinary palliative care team to 
develop a care plan for the patient; a meeting is held with the family to discuss the 
child’s prognosis and the options for care; the family is trained in the provision of 
basic care at home and provided emergency contact information for the palliative 
care services; and ultimately, in most cases, the child goes home where he or she 
receives regular visits from members of the palliative care team. 
  
In Toluca, by June 2014, the palliative care service had cared for 138 children with 
terminal or incurable illnesses since it began operating in February 2013. At the time 
of the visit, 59 of these patients had passed away, more than half in their homes. In 
its first year, the palliative care service in Cuernavaca had cared for 58 children. 
Three quarters of the forty-five who had passed away did so in their homes. 
                                                          
72 This text box is based on visits to the Hospital del Niño in Toluca on June 16, 2014 and to Hospital del Niño in Cuernavaca 
on June 18, 2014. 
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The directors and staff at both hospitals said that feedback from patients and their 
families on the palliative care service had been very positive. Furthermore, they also 
noted that hospital stays for these children were often shorter than before, 
potentially leading to cost savings for the hospital. They said this was particularly 
true for children who require round-the-clock ventilators due to severe neurological 
or congenital malformations. Previously, many of these children had no option but to 
stay in the hospital for extended periods of time whereas the palliative care services 
have allowed many of them to obtain these services at home. 
  
Both hospitals also reported challenges. The palliative care teams said that in the 
beginning, they had encountered significant resistance on the part of some 
physicians who did not want to refer their child patients to palliative care. They said 
that over time they had overcome much of this reluctance through training and direct 
experiences. Many physicians now recognize the benefits of palliative care for their 
young patients. However, the hospitals cited lack of adequate staff and insurance 
coverage for palliative care and difficulties prescribing opioid medicines as 
challenges. 
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III. Exploring the Causes for the Palliative Care Gap 
 
The WHO and its decision-making body, the World Health Assembly (WHA), recommend 
the integration of palliative care into national health systems. To achieve this, the WHO 
recommends that governments formulate and implement a number of specific policies that 
it considers essential for expanding palliative care, including: 
 
• Health system policies to ensure the integration of palliative care into the structure 
and financing of national health care systems at all levels of care; 
• Policies for strengthening and expanding human resources, including education 
and training of health care professionals, in order to ensure adequate responses to 
the palliative care needs, together with training of volunteers and education of the 
public; 
• A medicines policy in order to ensure the availability of essential medicines for the 
management of symptoms, including pain and psychological distress, and in 
particular, opioid analgesics for relief of pain and respiratory distress; 
• A policy for research into assessing the needs for palliative care and identifying 
standards and models of service that work, particularly in limited resource 
settings.73 
 
A World Health Assembly resolution on palliative care adopted on May 23, 2014, which 
Mexico co-sponsored, closely mirrors these recommendations.74 
 
These recommendations also correspond closely with several obligations under the right 
to health. The Committee on Economic, Social and Cultural Rights, the body that monitors 
the implementation of the right to health as articulated in the International Covenant on 
Economic, Social and Cultural Rights (ICESCR),75 has held that countries must adopt and 
                                                          
73 WHO, “Strengthening of Palliative Care as a Component of Integrated Treatment throughout the Life Course,” 
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_28-en.pdf. 
74 WHA resolution 67.19, Strengthening of Palliative Care as a Component of Comprehensive Care throughout the Life Course, 
May 14, 2014, http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf (accessed June 26, 2014). 
75 International Covenant on Economic, Social and Cultural Rights (ICESCR), adopted December 16, 1966, G.A. Res. 2200A 
(XXI), 21 U.N. GAOR Supp. (No. 16) at 49, U.N. Doc. A/6316 (1966), 993 U.N.T.S. 3, entered into force January 3, 1976, art. 12; 
also in the Convention on the Rights of the Child (CRC), G.A. res. 44/25, annex, 44 U.N. GAOR Supp. (No. 49) at 167, U.N. Doc. 
A/44/49 (1989), entered into force September 2, 1990, art. 12. 
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implement a national public health strategy and plan of action and ensure access to 
essential medicines as defined by the WHO.76 It has identified providing appropriate 
training for health personnel as an obligation “of comparable priority.”77 Failure to take 
steps in these three areas may result in a violation of the right to health. 
 
Integration of Palliative Care into the Healthcare System 
According to the WHO, national health system policies should promote the integration of 
palliative care into the structure and financing of national health care systems at all levels 
of care. In these policies, the emphasis should be on primary care, community and home-
based care.78 The WHO also recommends that palliative care be part of efforts to promote 
universal health coverage. 
 
The right to health requires states to take the steps necessary for the “creation of 
conditions which would assure to all medical service and medical attention in the event of 
sickness” (emphasis added).79 The Committee on Economic, Social and Cultural Rights has 
held that people are entitled to a “system of health protection which provides equality of 
opportunity for people to enjoy the highest attainable level of health.”80 In other words, 
health services should be available for all health conditions, including chronic or terminal 
illness, on an equitable basis. 
 
The 2009 palliative care amendments to Mexico’s health law are closely in line with these 
WHO recommendations and human rights obligations. The amendments explicitly oblige 
all healthcare institutions to offer palliative care services, including counseling about 
illness, treatment of pain and psychological support. This is only possible with the 
integration of palliative care into the structure and financing of the healthcare system. A 
                                                          
76 UN Committee on Economic, Social and Cultural Rights, “Substantive Issues Arising in the Implementation of the 
International Covenant on Economic, Social and Cultural Rights,” General Comment No. 14, The Right to the Highest 
Attainable Standard of Health, E/C.12/2000/4 (2000), 
http://www.unhchr.ch/tbs/doc.nsf/(Symbol)/40d009901358b0e2c1256915005090be?Opendocument (accessed May 11, 
2006), para. 43. 
77 Ibid., para 44(f). 
78 WHO, “Strengthening of Palliative Care as a Component of Integrated Treatment throughout the Life Course,” 
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_28-en.pdf, p 20(i). 
79 ICESCR, art. 12 (2). 
80 UN Committee on Economic, Social and Cultural Rights, General Comment No. 14, para 8. 
  57 HUMAN RIGHTS WATCH | OCTOBER 2014 
February 2013 meeting on the role of palliative care in Mexico’s national cancer strategy 
clearly identified this as a priority.81 
 
As noted, however, implementation has lagged as the ministry of health has yet to adopt the 
implementing norm for the amendments. As a result the actual integration of palliative care 
into the structure of the healthcare system at all levels of care has not happened to date. 
Mexico has made some significant advances at the tertiary level of care where a growing 
number of hospitals are now offering palliative care as a core part of their health services. 
But at secondary and primary care levels palliative care is still mostly non-existent. 
 
Integration of Palliative Care into Health Insurance Schemes 
With most of its population covered by a health insurance scheme, Mexico has the 
infrastructure to deliver palliative care to most people who need it. However, the availability 
of palliative care services among providers in the networks of these insurers is very limited 
and one major health insurer only covers palliative care partially for most patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
81 Silvia Allende-Pérez, Emma Verástegui-Avilésb, Alejandro Mohar-Betancourt, et al., “Incorporación de los cuidados 
paliativos al Plan Nacional de Cáncer: consenso,” Gaceta Mexicana de Oncología 12 (2013):213-222, accessed June 27,2014, 
http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_articulo=99984&id_seccion=2290&id_ejemplar
=9742&id_revista=139.  
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Seguro Popular 
Prior to 2014, Seguro Popular did not cover palliative care for many conditions, including 
many cancers. The 2012 list of basic medical interventions and medicines, the Universal 
Catalogue of Health Services, that are covered under the insurance, for example, did not 
include a specific intervention for palliative care or include a number of key symptoms that 
many palliative care patients face, such as pain and breathlessness.82 This meant that the 
several dozen public hospitals that attend to Seguro Popular patients and that do have 
palliative care available had to charge them for such services or had to provide them free-
of-charge without possibility of being reimbursed.  
 
To address this gap in coverage, the National Commission for Social Protection of Health 
(NCSPH), which administers Seguro Popular, added an intervention entitled “Attention for 
certain signs, symptoms, and other factors that influence the state of health” to the 2014 
                                                          
82 Seguro Popular, “Catálogo Universal de Servicios de Salud,” 2012, 
http://www.seguropopularoaxaca.gob.mx/documentos/CAUSES2012.pdf (accessed June 27, 2014).  
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catalogue which includes various common symptoms in palliative care patients, including 
pain and breathlessness.83 Each intervention in the catalogue comes with a list of 
recommended medicines. Yet, curiously, the list of medicines for the intervention on 
control of symptoms does not include any opioid pain medicines, even though injectable 
morphine, tramadol, and buprenorphine were added to Seguro Popular’s general 
medicines list.84 While physicians can prescribe any of the medicines on Seguro Popular’s 
list for any covered condition, the lack of inclusion of key pain medicines with the 
intervention on symptom control may well discourage physicians from using them. The 
NCSPH is currently reviewing the financial feasibility of adding coverage of a more 
comprehensive set of palliative care interventions in the future.85 
 
The Fund for the Protection against Catastrophic Costs (Fondo de Protección contra Gastos 
Catastróficos), which covers certain complex medical conditions that generally involve 
major expenditure for treatment, including all pediatric cancers, some adult cancers and 
HIV, also does not cover palliative care adequately.86 While the Fund covers diagnostic 
tests and curative treatment for these illnesses, the Fund’s documentation is not explicit 
on whether its beneficiaries are entitled to receive palliative care.87 The Fund’s essential 
medicines list does include various strong opioid analgesics.88 
 
                                                          
83 See intervention no. 88 in the Universal Catalogue of Health Services (Catálogo Universal de Servicios de Salud) of March 
2014. The other symptoms covered include, among others: palpitations, bleeding from the nose, cough, hyperventilation, 
nausea, vomiting, skin conditions, flatulence, involuntary movements, fainting, and fatigue. On file with Human Rights 
Watch. 
84 Ibid. 
85 Email correspondence with Celina Castañeda of the National Commission for Social Protection in Health, September 12, 
2014. 
86 “Intervenciones Del Fondo De Protección Contra Gastos Catastróficos 2012,” undated, 
http://www.saludzac.gob.mx/site/images/stories/SeguroPopular/FormatosPDF/1intervencionesfpcgc2012.pdf (accessed 
June 27, 2014). 
87 Ibid. 
88 Published in the Diario Oficial de la Federación on November 30, 2012. Available at: 
http://www.dof.gob.mx/nota_detalle.php?codigo=5281003&fecha=30/11/2012 (accessed June 27, 2014). 
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Mexican Social Security Institute (IMSS) 
IMSS will cover palliative care interventions and medicines.89 However, few IMSS hospitals 
and clinics actually offer palliative care services. We identified just three tertiary care 
hospitals within the IMSS system—in Mexico City, Monterrey, and Cuernavaca—that offer 
palliative care and none at the secondary level.90 Thus, although palliative care in theory is 
covered for patients with IMSS, most cannot actually access it because of its limited 
availability. IMSS’ medicines list includes most essential palliative care medicines that are 
available in Mexico (see below under Medicines Availability), although not all are available 
at primary and secondary levels of care. 
 
                                                          
89 IMSS does not have a published list of interventions that are covered. However, IMSS officials informed us that in 
principle all palliative care interventions an IMSS-associated physician deems necessary are covered. Meeting with Javier 
Dávila, director of medical services, Pedro Escudero, director of Hospital de Oncología of the National Medical Center Siglo 
XXI, Víctor Borja, director of the unit for primary health care, and Manuel Cervantes, coordinator of integral primary health 
care, June 18, 2014, México City, organized by Fundación Mexicana para la Salud and Tómatelo a Pecho. 
90 Another eleven IMSS hospitals have pain clinics. 
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IMSS has a home-based care program for people with chronic illnesses at 140 of its 
general and specialist hospitals, which attended to 35 thousand patients in 2013 and 
could be a good vehicle for delivering palliative care.91 However, at present the program is 
designed for patients with long-term care needs rather than for those with a prognosis of 
short-term survival and health needs that require immediate assistance. The program has 
limited capacity which means that patients with advanced illness cannot always enroll 
immediately. Furthermore, staff of these home-based care programs are not currently 
trained in the provision of palliative care. 
 
IMSS boasts an award winning palliative care service in Monterrey, Nuevo León, that 
serves several states in northeastern Mexico.92 This service, which operates out of Unidad 
Medica de Alta Especialidad 25 (UMAE 25), uses a decentralized model to assist patients. 
The service has invested extensively in training primary care physicians in the 
northeastern region and refers patients to primary care givers for day-to-day care. For 
prescriptions for opioid analgesics and more complex symptom management patients do 
still need to travel to Monterrey but the cooperation with primary care givers has reduced 
the need for patients to travel back-and-forth. The director of UMAE 25 credits the palliative 
care service with a significant reduction of bed occupancy in the hospital’s oncology unit.93 
 
 
                                                          
91 The program is called ADEC (Atención domiciliaria al enfermo crónico). Data received from IMSS, communication of 
October 13, 2014. http://www.cronica.com.mx/notas/2008/352686.html (accessed October 3, 2014). 
92 In 2009, the palliative care service was an award for innovation in the quality of healthcare. Human Rights Watch interview 
with Dr. José Alberto Flores Cantisani, Monterrey, Nuevo León, October 8, 2013. 
93 Human Rights Watch interview with Dr. Pablo Moreno, Monterrey, Nuevo León, October 8, 2013. 
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Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE) 
ISSSTE does not appear to have a public list of the medical conditions and interventions it 
covers or a public medicines list. However, key informant interviews suggest that palliative 
care interventions, such as management of physical and psychosocial symptoms, are 
covered when available. We identified five of a total of 110 ISSSTE hospitals—in Chiapas, 
Chihuahua, Mexico City, Guanajuato and Puebla—that have palliative care services.94 
 
Lack of Referral Systems 
The WHO and the WHA resolution recommend that people who require palliative care can 
receive it in their home or community. International human rights standards hold that 
health services should be within “safe physical reach for all sections of the population, 
especially vulnerable and marginalized groups.”95 This is only possible with the existence 
                                                          
94 We also identified eleven ISSSTE hospitals that have pain clinics. ISSSTE hospitals were identified through the health 
ministry’s website: http://plataforma.salud.gob.mx:8091/ (accessed September 29, 2014). 
95 UN Committee on Economic, Social and Cultural Rights, General Comment No. 14, para 12b. 
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of palliative care capacity at the primary care level, which is sorely lacking in Mexico. It 
also requires a functioning referral system so that patients who become incurable are 
referred back to healthcare providers in or close to their communities.  
 
As testimony from people with life-limiting illnesses and their families above shows clearly, 
such a system does not currently exist in Mexico even when community or home-based 
palliative care services are available. Palliative care services and their capacities are 
currently not recorded or circulated in any way, complicating referrals. For example, 
organograms of Mexico’s hospitals do not include palliative care services or pain clinics. 
 
Some hospitals have set up their own referral systems. For example, through its extensive 
training activities, the palliative care unit of Instituto Nacional de Ciencias Médicas y 
Nutrición Salvador Zubirán in Mexico City has built up a network of trained physicians in 
many parts of the country that it refers patients to when they finish their hospital treatment 
so that they no longer have to travel to Mexico City to receive palliative care services.96 The 
National Cancer Institute works with a network of cancer centers that includes 33 hospitals 
around the country, 18 of which have palliative care units, although three of the states 
where most of their patients come from, Hidalgo, Morelos, and Tlaxcala, do not have 
regional cancer centers.97 UMAE 25 of IMSS in Monterrey has developed its own referral 
system to primary physicians in Nuevo León and adjacent states by investing in training of 
primary care physicians in palliative care. When patients are ready to be sent home, the 
hospital draws up referral instructions for primary physicians so that they can offer 
services to patients close to their homes.98 
 
Palliative Care Education for Healthcare Workers 
Adequate training and education for healthcare workers in palliative care is essential to 
the rollout of this health service. As noted above, the Committee on Economic, Social and 
Cultural Rights considers appropriate training of healthcare workers an obligation of key 
importance.99 Accordingly, the WHO recommends that “education about palliative care 
                                                          
96 Human Rights Watch interview with Dr. Argelia Lara, September 20, 2011, México City. 
97 Email correspondence with Dr. Emma Verástegui, July 10, 2014. 
98 Human Rights Watch interview with Dr. José Alberto Flores Cantisani, Monterrey, Nuevo León, October 8, 2013. 
99 UN Committee on Economic, Social and Cultural Rights, “Substantive Issues Arising in the Implementation of the 
International Covenant on Economic, Social and Cultural Rights,” General Comment No. 14, The Right to the Highest 
Attainable Standard of Health, E/C.12/2000/4 (2000), 
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(including ethical aspects) is offered to students in undergraduate medical and nursing 
schools and to health care providers at all levels…”100 The May 2014 World Health 
Assembly resolution calls on countries to include palliative care as an “integral component 
of the ongoing education and training offered to care providers” and specifies: 
 
(a) basic training and continuing education on palliative care should be integrated 
as a routine element of all undergraduate medical and nursing professional 
education, and as part of in-service training of caregivers at the primary care level, 
including health care workers, caregivers addressing patients’ spiritual needs and 
social workers;  
 
(b) intermediate training should be offered to all health care workers who routinely 
work with patients with life-threatening illnesses, including those working in 
oncology, infectious diseases, paediatrics, geriatrics and internal medicine;  
 
(c) specialist palliative care training should be available to prepare health care 
professionals who will manage integrated care for patients with more than routine 
symptom management needs.101 
 
To date, palliative care has not yet been integrated into curricula and continuing education 
programs for healthcare workers. Mexico City and Guadalajara each have multiple training 
programs for different kinds of healthcare workers and at different levels but in the rest of 
the country such programs are almost entirely non-existent. As a result, most healthcare 
workers in Mexico have no knowledge of palliative care and lack any clinical exposure to 
this health service, greatly complicating efforts to integrate palliative care into the 
healthcare system. 
 
Research by the Latin American Palliative Care Association (ALCP) on palliative care in 
Mexico demonstrates the extent of the training capacity gap (see Table 2).102 It found that 
                                                                                                                                                                             
http://www.unhchr.ch/tbs/doc.nsf/(Symbol)/40d009901358b0e2c1256915005090be?Opendocument (accessed May 11, 
2006), para 44(f). 
100 WHO, “Strengthening of Palliative Care as a Component of Integrated Treatment throughout the Life Course,” 
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_28-en.pdf. 
101 WHA resolution 67.19, Strengthening of Palliative Care as a Component of Comprehensive Care throughout the Life Course, 
http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R19-en.pdf. 
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just six medical schools in Mexico teach palliative care as part of the curriculum and that it 
is mandatory in just two.103 Mexico has a total of 102 medical schools.104 A recent 
publication in the journal Palliative Medicine found that Mexico ranked 12th of 19 countries 
in the region in integration of palliative care into undergraduate medical curricula.105 
According to the report, the Asociación Mexicana de Facultades y Escuelas de Medicina, 
which is made up of 54 medical schools and makes non-binding recommendations about 
medical curricula, plans to include palliative care into its model curricula.106 Mexico’s 
universities enjoy wide discretion in setting curricula for their academic programs, 
complicating any potential efforts by the government to ensure palliative care is taught in 
medical schools and other relevant university courses. 
 
According to the ALCP study, just four nursing schools, three faculties of psychology, and 
two faculties of social work include palliative care as part of their curricula. The report 
identified forty-five medical doctors who teach palliative care and 25 non-medical palliative 
care trainers. It said about 250 medical doctors had completed palliative care courses. 
 
The ALCP study did not seek to identify to what extent palliative care is integrated into 
continuing education programs for medical doctors, nursing staff, psychologists, 
pharmacists and social workers. The need for such programs is enormous as most existing 
healthcare workers have not had any training or clinical exposure to palliative care. 
 
To date, there have not been any concerted efforts by the government, the healthcare 
system or academic institutions to systematically incorporate palliative care into training 
curricula and programs for healthcare workers. This may change now that the health 
                                                                                                                                                                             
102 Asociación Latinoamericana de Cuidados Paliativos, “Atlas de Cuidados Paliativos de Latinoamérica, Edición 
cartográfica,’’ 2013, http://cuidadospaliativos.org/uploads/2014/3/Atlas%20Latinoamerica%20-
%20edicion%20cartografica.pdf, pp. 46, 47. 
103 The Atlas states that five medical schools have included palliative care into the undergraduate curriculum. However, the 
authors have informed us of a sixth medical school. Communication with Tania Pastrama of ALCP, April 14, 2014. 
104 Presentation by Giota Panopoupou, department of integration and development in the health sector, Ministry of Health at 
the Second International Forum “Toward Effective Universality of the Health System: Access to Palliative Care and Pain 
Control,” October 13, 2014. 
105 Tania Pastrana, Isabel Torres-Vigil, and Liliana De Lima, “Palliative care development in Latin America: An analysis using 
macro indicators, Palliative Medicine,” 2014, 
http://pmj.sagepub.com/content/early/2014/06/12/0269216314538893.full.pdf?ijkey=czz8VDFCw7mw3ce&keytype=ref 
(accessed July 15, 2014). 
106 Asociación Latinoamericana de Cuidados Paliativos, “Atlas de Cuidados Paliativos de Latinoamérica, Edición 
cartográfica,’’ http://cuidadospaliativos.org/uploads/2014/3/Atlas%20Latinoamerica%20-%20edicion%20cartografica.pdf, 
p 47. 
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ministry has hired a palliative care physician with extensive training experience to help it 
develop its work plan in this area. 
 
Table 2 – Palliative Care Education107 
 Medical schools Nursing schools Psychology Social work 
Un
de
rg
ra
du
at
e 
- Universidad Autónoma 
de Guadalajara 
(mandatory) 
- Universidad de 
Guadalajara (mandatory) 
- Universidad 
Panamericana (elective) 
- Universidad Nacional 
Autónoma de Mexico 
(UNAM) (elective) 
- Universidad La Salle 
(elective) 
- Instituto Politécnico 
Nacional (elective) 
- Universidad de 
Guadalajara 
(mandatory).*  
 
- Universidad 
Autónoma de 
Guadalajara 
(elective) 
- Universidad Jesuita 
de Guadalajara 
(ITESO) 
(mandatory)* 
 
 
 
- UNIVA (elective)* 
 
Po
st
gr
ad
ua
te
 (6
-1
2 
m
on
th
 d
ip
lo
m
a 
co
ur
se
s)
 - UNAM 
- Universidad de 
Guadalajara 
- Universidad Autónoma 
de Guadalajara 
 
 
- UNAM 
- Universidad de 
Guadalajara 
- Universidad 
Autónoma de 
Guadalajara 
- Centro de Cuidados 
Paliativos en Mexico 
- UNAM 
- Universidad de 
Guadalajara 
- Universidad 
Autónoma de 
Guadalajara 
- UNAM 
- Universidad de 
Guadalajara 
- Universidad 
Autónoma de 
Guadalajara 
- Centro de 
Cuidados 
Paliativos en 
Mexico 
Sp
ec
ia
lis
t (
on
ly
 fo
r 
ph
ys
ic
ia
ns
) 
- Universidad Nacional Autónoma de Mexico has a one-year specialization course for doctors 
specialized in internal medicine, psychiatry, geriatrics, oncology or algiology. 
- The National Institute of Pediatrics offers a super specialization course in pediatric palliative care for 
pediatricians. 
- The Institute Jalisciense de Alivio al Dolor y Cuidados Paliativos, the General Hospital of the West and 
the University of Guadalajara offer a two-year subspecialty program in palliative and pain medicine. 
- The Autonomous University of Guadalajara plans to start a master’s program in palliative care in 
March 2015. 
* The Atlas does not list the names of the nursing schools, faculties of psychology, and faculties of social work that 
offer palliative care courses in their undergraduate curricula. Human Rights Watch has listed the schools and 
faculties it was able to confirm. 
                                                          
107 Ibid. 
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In July 2014, the Mexican Social Security Institute (IMSS), one of Mexico’s major health 
insurers, decided to include children’s palliative care into the training program for 
residents specializing in pediatrics at its affiliate hospitals. Palliative care had previously 
been included in the curriculum in Guadalajara, where 8 hours of pediatric palliative care 
have been taught to third year residents in pediatrics since 2011 under “Emerging illnesses 
and problems.”108 
 
Medicines Availability 
The WHO recommends that countries adopt a “medicines policy in order to ensure the 
availability of essential medicines for the management of symptoms, including pain and 
psychological distress, and in particular, opioid analgesics for relief of pain and 
respiratory distress.”109 In 2013, the WHO created sections on pain and palliative care in its 
Model List of Essential Medicines and its Model List of Essential Medicines for Children. 
These sections contain medicines and specification for formulations that the WHO 
considers essential for pain management and palliative care. 
 
Under the right to health, countries are required to ensure the availability and accessibility 
of all medicines included in the WHO Model List of Essential Medicines. The Committee on 
Economic, Social and Cultural Rights has held that providing essential medicines as 
determined by the WHO is a core obligation that cannot be limited by claims of limited 
resources, but states should fulfill immediately.110 
 
As discussed above, there are still significant challenges in Mexico with the availability 
and accessibility of opioid analgesics. As a study by the Pain and Policy Studies Group at 
the University of Wisconsin found in 2013, Mexican law contains various provisions that 
strongly support the need to make opioid analgesics available for medical purposes.111 
However, implementing regulations create numerous complications in practice, which are 
                                                          
108 Human Rights Watch communication with Dr. Yuriko Nakashima, July 11, 2014. 
109WHO, “Strengthening of Palliative Care as a Component of Integrated Treatment throughout the Life Course,” 
http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_28-en.pdf. 
110 UN Committee on Economic, Social and Cultural Rights, General Comment No. 14: The right to the highest attainable 
standard of health, November 8, 2000, para. 43. The Committee on Economic, Social and Cultural Rights is the UN body 
responsible for monitoring compliance with the International Covenant on Economic, Social and Cultural Rights. 
111 Pain & Policy Studies Group. Improving Global Opioid Availability for Pain & Palliative Care: A Guide to a Pilot Evaluation 
of National Policy. (Madison: University of Wisconsin Carbone Cancer Center, 2013).  
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explored in this chapter. While the situation with accessibility of other essential palliative 
care medicines is better, we also explore challenges in this area. 
 
Access to Opioid Analgesics 
 
You have to help the patient first. If we aren’t able to help the patient, the 
regulations are not good. - Dr. Juan José Lastra, Ajijic, Jalisco112 
 
Opioid analgesics are essential for the management of pain, shortness of breath and 
several other common symptoms among people who need palliative care. Because opioid 
medicines are controlled substances, countries must regulate how they can be produced, 
distributed, prescribed and dispensed. The 1961 Single Convention on Narcotic Drugs, the 
international agreement that provides the framework for national drug control efforts, 
contains four basic requirements for national regulations of controlled medicines: 
 
- Individuals dispensing the medication must be licensed, either by virtue of their 
professional license or through a special licensing procedure;  
- The medications may only be transferred between authorized institutions or 
persons;  
- The medications can only be dispensed to a patient upon a medical prescription;113 
and  
- Records on the movement of these medications are kept for no less than two 
years.114  
 
The Single Convention specifically allows countries to put in place additional requirements, 
including a special prescription form for controlled medications. Countries, however, have 
a dual obligation with respects to these medicines: they must ensure their adequate 
availability for medical and scientific use while preventing their misuse and diversion.115 
                                                          
112 Human Rights Watch interview with Dr. Juan José Lastra, November 11, 2011, Ajijic, Jalisco. 
113 1961 Single Convention on Narcotic Drugs, Article 30(2bii). 
114 Ibid, Article 34. 
115 INCB, “Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring 
Adequate Access for Medical and Scientific Purposes,” February 2011, 
http://www.incb.org/documents/Publications/AnnualReports/AR2010/Supplement-AR10_availability_English.pdf 
(accessed July 11, 2014); INCB, “Availability of Opiates for Medical Needs: Report of the International Narcotics Control Board 
for 1995,” http://www.incb.org/pdf/e/ar/1995/suppl1en.pdf (accessed June 28, 2014), p. 1. 
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Countries must take care that any additional requirements to those specified in the 1961 
Single Convention do not unnecessarily impede medical access.116 
 
As noted, international human rights standards require that countries ensure the 
availability and accessibility of opioid analgesics that are included in the WHO Model List 
of Essential Medicines. As the manufacturing, prescribing, and dispensing of controlled 
medicines is subject to strict regulation by governments, states have an obligation to 
ensure these regulations do not unnecessarily restrict patient access to them for medical 
purposes. Any regulations that arbitrarily impede the procurement and dispensing of these 
medications for medical purposes are incompatible with the right to health. 
 
Numerous challenges currently exist with the prescribing of opioid analgesics due to 
burdensome requirements for physicians and strict and inflexible dispensing rules for 
these medicines. Mexico’s health law and a regulation on medical products and 
instructions from the country’s pharmaceuticals commission set out the rules for 
prescribing and dispensing medicines.117  
 
The Mexican government, however, has announced significant changes to the prescribing 
system for opioid analgesics.118 In making the announcement, COFEPRIS stated specifically 
that these changes aim to improve access to controlled medicines such as morphine for 
patients with terminal illness.119 Under the new system, which is expected to be 
operational in the first quarter of 2015, many of the barriers identified here should seize to 
exist. The specific changes that are being prepared are discussed below, along with 
descriptions of current barriers. 
 
                                                          
116 WHO, “Cancer Pain Relief, Second Edition, With a Guide to Opioid Availability,” 1996, 
http://whqlibdoc.who.int/publications/9241544821.pdf (accessed June 27, 2014), p. 9. 
117 The General Health Law is available at http://www.salud.gob.mx/unidades/cdi/legis/lgs/LEY_GENERAL_DE_SALUD.pdf 
(accessed on July 15, 2014); the Regulation on Health Products (Reglamento de Insumos para la Salud), available at 
http://www.salud.gob.mx/unidades/cdi/nom/compi/ris.html (accessed July 15, 2014); FEUM y Secretario de Salud, 
Suplemento para establecimientos dedicados a la venta y suministro de medicamentos y demás insumos para la salud, 
edición 4, México 2010. 
118 Announcement of the ministry of health and COFEPRIS of March 28, 2014, available at: http://t.co/DXLVO444PJ (accessed 
June 27, 2014). 
119 Announcement of the ministry of health and COFEPRIS of March 28, 2014, available at: http://t.co/DXLVO444PJ (accessed 
June 27, 2014). 
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Obtaining Prescription Rights 
Under current Mexican law, a physician must obtain a special license, triplicate 
prescription forms, and barcoded stickers in order to be able to prescribe opioid 
analgesics.120 These requirements go well beyond what the 1961 Single Convention 
mandates. The WHO has noted that requirements for duplicate prescriptions and special 
prescription forms increases the administrative burden both for healthcare workers and 
drug control authorities. It has stated that this problem is “compounded if forms are not 
readily available, or if health professionals need to pay for them.” It recommends that 
countries should “ensure that this system does not impede the availability and 
accessibility of controlled medicines.”121 
 
Obtaining the license to prescribe opioid analgesics. In order to obtain the license to be 
allowed to prescribe opioids, the medical doctor must apply to the health department or 
COFEPRIS office in their state.122 This can only be done in the state capital and must be 
done in person, a disincentive for doctors who work outside of capital cities. The license is 
generally not issued the same day, meaning doctors may have to return a second time to 
finalize proceedings. Although an explanatory note of the health ministry and COFEPRIS 
clearly states the process is free of charge, some Mexican states charge an application fee 
for obtaining the license, creating an additional financial burden (see Table 3 below).123 
Under the changes that are being prepared, physicians will be able to request and obtain 
these licenses through an online procedure and will no longer have to make physical 
appearances as part of this process.124 
 
The special prescription form. Physicians must order special triplicate prescription forms 
in order to prescribe opioid analgesics, again requiring additional expenditure on their 
part. Problematically, the rules for these forms require that they contain the physician’s 
                                                          
120 See Ley General de Salud, article 241, for the requirement that prescriptions contain a barcoded sticker. More detailed 
requirements can be found in the Suplemento of 2010, p. 147. 
121 WHO, “Ensuring Balance in National Policies on Controlled Substance: Guidance for Availability and Accessibility of 
Controlled Medicines,” 2011, http://whqlibdoc.who.int/publications/2011/9789241564175_eng.pdf?ua=1 (accessed July 11, 
2014), p.28. 
122 See article 51 of the regulation on health products (Reglamento de Insumos para la Salud) and the suplemento. The 
Ministry of Health and COFEPRIS also issued an explanatory note (circular in Spanish) in October 2005 which contains 
additional details on the process. The explanatory note can be found at 
http://www.ipomex.org.mx/ipo/archivos/downloadAttach/167845.web;jsessionid=0DD959939C1E283B82E8B99C6399363
2 (accessed July 11, 2014). 
123 See Explanatory note of October 2005. 
124 Human Rights Watch meeting with Mikel Arriola-Peñalosa, commissioner of COFEPRIS, September 3, 2014. 
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home address.125 This requirement does not appear to serve any useful purpose from a 
drug control or medical perspective but does pose a potential security risk for the 
prescribing physician. Several doctors told us that this requirement is a deterrent. As one 
doctor commented, “I only give my home address to people I trust, not to everybody. So I 
don’t know why your house phone and your address have to be in the prescription.”126 The 
government has announced that this requirement will be eliminated.127 
 
Bar coded stickers. The most significant disincentive to prescribing opioid analgesics is 
the very unusual requirement in Mexico’s general health law that prescriptions for these 
medications must carry a barcoded sticker.128 A variety of factors makes the current system 
for barcoded stickers very user-unfriendly and discourages physicians from prescribing 
these medications: 
 
• The stickers can only be issued by the health and sanitation authorities at one 
location in each state’s capitals, usually the health ministry or COFEPRIS office, 
which are open only during business hours.129  
 
• Doctors must collect the stickers in person.130 
 
• Regulations allow health departments to issue only fifty pairs of stickers at once.131 
 
• In most states, the stickers are not prepared immediately so the physician must 
return to collect them later, sometimes several weeks later. 
                                                          
125 See Suplemento, p. 147. The requirement does not appear to be uniformly enforced. Several doctors told us that their 
work address or the address of their private clinic is on the prescription form rather than their home address. 
126 Human Rights Watch interview with Dr. Juan José Lastra, November 11, 2011, Chapala, Jalisco. 
127 Human Rights Watch meeting with Mikel Arriola-Peñalosa, commissioner of COFEPRIS, September 3, 2014. 
128 Article 241, Ley General de Salud. One sticker must be placed on the copy of prescription for the pharmacy, another on 
the copy for the patient. The physician’s copy does not require the sticker. In some hospitals, such as the National Cancer 
Institute, doctors are allowed to write internal hospital prescription forms for medications of Group I that patients can fill at 
the pharmacy of that hospital. In such cases, no barcoded stickers are needed. However, this appears to be practiced only in 
some hospitals.  
129 See explanatory note of October 2005. 
130 Some physicians told us they are allowed to send someone else to request the barcoded stickers for them. 
131 Official instructions regarding the prescription of controlled medicines belonging to group I specify that the first time a 
doctor requests barcoded stickers, the health authority issues a set of fifty (Suplemento, p. 147). The instructions do not 
specify a limit for subsequent requests but October 2005 explanatory note specifies that barcoded stickers are always 
provided in sets fifty. This rule, however, has not been followed strictly as some physicians have been able to get a hundred 
pairs of stickers at a time. At a round table on palliative care in June 2014 in México City in which Human Rights Watch 
participated, representatives of COFEPRIS said that the agency is now routinely issuing a hundred pairs of stickers to 
facilitate the prescribing of controlled medicines. 
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• Some states charge physicians for barcoded stickers (see Table 3). 
 
• Some of the machines used to print the stickers are outdated and are reported to 
break down frequently, resulting in states being unable to issue new stickers for 
weeks or even months at a time.132 
 
This system is difficult for all physicians but especially for those who live outside of state 
capitals. They must travel to the state capital—a trip that can often take hours—at least 
once for every batch of barcoded stickers they need. If the health department or COFEPRIS 
do not issue the stickers immediately, they may have to travel a second time. If the 
machine that prints the stickers is broken, a trip to the capital can be altogether futile. 
 
A general practitioner in Ajijic, about an hour away from Guadalajara, told Human Rights 
Watch that he needs a new set of fifty barcoded stickers every two weeks and thus has to 
make the trip to the city every fortnight. He said that he loses half a day of work each 
time.133 Another doctor from the same town said he has to close his private clinic early on 
days he needs to travel to Guadalajara to pick up barcoded stickers:  
 
My consultations are in the mornings and they [the health department] are 
open only in the mornings. So some days I’ll have to go at 1pm as they 
close at 3pm. For me it means losing patients or seeing fewer patients.134 
 
 
 
 
 
 
 
 
 
 
 
                                                          
132 COFEPRIS has been replacing these machines with a new system that allows barcoded stickers to be printed from any 
printer. 
133 Human Rights Watch interview with Dr. Juan José Lastra, November 11, 2011, Chapala, Jalisco. 
134 Human Rights Watch interview with Dr. Carlos García, November 11, 2011, Chapala, Jalisco. 
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Table 3 – Fees for Licenses to Prescribe Opioids and Barcoded stickers135 
State Charge for License Charge per set of 50 
stickers 
Processing of 
Stickers 
Baja California Sur 606 pesos (US$46.69) 472 pesos (US$36.36) 5 days   
Chiapas 650 pesos (US$50.8) No charge 10 days 
Colima No charge 887 pesos (US$68.34) 5 days   
Mexico State 318.85 pesos (US$25.56) 
or 336 pesos 
(US$25.89)* 
318.85 pesos 
(US$25.56) or 336 
pesos (US$25.89)* 
2 days 
Guerrero 1228 pesos (US$86.90) 
or 1295 pesos 
(US$99.77)* 
614 pesos (US$47.30) 
or 648 pesos 
(US$49.92)* 
10 days  
Querétaro No charge 200 pesos (US$15.41) Not available 
San Luis Potosí 638 pesos (US$49.15) 638 pesos (US$49.15) Not available  
Sinaloa No charge 150 pesos (US$11.56) Not available 
Tamaulipas 63.77 or 67.29 pesos 
(US$4.91 or 5.18)]*  
63.77 or 67.29 pesos 
(US$4.91 or 5.18)]* 
26 days  
Yucatán No charge 689 pesos (US$53.08) 3-4 days 
* The higher fees generally apply in major urban areas. 
  
Even for physicians who live in state capitals, collecting the barcoded stickers can be a 
time-consuming affair. In Mexico City, a city of almost nine million people and notoriously 
heavy traffic, there is just one office, the headquarters of COFEPRIS, that can issue the 
stickers. Opening hours are 8am to 2pm, coinciding exactly with hours of medical consults 
in most hospitals. Dr. Argelia Lara, the head of the pain clinic at Instituto Nacional de 
                                                          
135 This table is based on information received through requests under México’s freedom of information act in 2012 
(Campeche, Chiapas, Colima, Durango, Querétaro, Quintana Roo, San Luis Potosí, and Sinaloa), web searches (Campeche, 
Chiapas, Colima, Durango, Guerrero, Querétaro, Quintana Roo, and Tamaulipas), and phone calls (Baja California Sur, 
México State, San Luis Potosí, Tamaulipas and Yucatan). In the cases of Campeche, Durango, and Quintana Roo, official 
responses to our freedom of information requests indicated that the states charge for licenses or barcoded stickers 
(Campeche: 75 pesos (US$5.78) per set of barcoded stickers; Durango: 797.58 pesos (US$61.45) for license and per set of 
barcoded stickers; Quintana Roo: 63.77 to 637.70 pesos (US$4.91 to US$49.10) for the license) whereas government 
webpages, which were consulted in 2014, said the process was free. In some cases, the fee stated online differed from the 
one stated in responses to freedom of information requests (Chiapas reported that the cost of the license was 1118 pesos 
(US$86.13) in its response to the freedom of information request; San Luis Potosí responded that the charge for the license 
and per set of barcoded stickers was 591 pesos (US$45.53). We included the more recent information. In some states, the 
first set of barcoded stickers (México State and San Luis Potosí) is issued free of charge. All responses to freedom of 
information requests are on file with Human Rights Watch. 
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Ciencias Médicas y Nutrición Salvador Zubirán (hereinafter Hospital Nutrición), a tertiary 
level hospital in Mexico City, told us: 
 
By car it takes an hour to get to the office—if it isn’t rush hour, that 
is…another [hour] out there [at COFEPRIS] and another to return. In total 
three hours so you have to dedicate your whole morning to the process.136 
 
Moreover, COFEPRIS in Mexico City does not issue the barcoded stickers the same day. 
According to Dr. Lara, it usually takes two weeks before she can pick up the stickers. She 
notes that the waiting time varies greatly, making it difficult for her to plan. Dr. Lara uses a 
set of barcoded stickers every five weeks on average but the number of patients and their 
symptoms vary so it is important that she always has an ample supply of barcoded stickers. 
Otherwise, she may run out of them before having received a new set preventing her from 
prescribing opioid analgesics to patients who require them. 
 
As Table 3 shows, some states informed Human Rights Watch that they charge a fee for 
either the license to prescribe opioids, packages of barcoded stickers or both, despite the 
fact that COFEPRIS maintains the process of obtaining barcoded stickers is free of 
charge.137 It is unclear whether these charges are always enforced as some physicians told 
us that they were able to get the license or barcoded stickers free of charge even though 
the state government claims it charges a fee. 
Numerous physicians interviewed during our research complained that the machines used 
to print barcoded stickers were antiquated and regularly broke down. As there was only 
one machine per state, this resulted in serious problems for physicians and their patients 
when the machine was out of order. In Mexico City, for example, the machine broke down 
in 2012 and was out of order for a period of five months. Dr. Lara of Hospital Nutrición told 
Human Rights Watch: 
 
We did not have prescriptions for almost five months and they did nothing. 
[For a long time] there was no resolution and nobody was providing anyone 
any information on what was happening. 
 
                                                          
136 Human Rights Watch interview with Dr. Argelia Lara, México City. 
137 Response to freedom of information request 121510000212 of February 1, 2012. On file with Human Rights Watch. 
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She said that the situation has improved somewhat since that time: “Before it was horrible. 
The environment was chaotic. The system went down all the time. Now it is a bit better and 
the place is larger and has more personnel.”138 
 
The machine also broke down for an extended period of time in Veracruz in 2013. Dr. Rafael 
Contreras of the Centro Estatal de Cancerología del Estado de Veracruz told Human Rights 
Watch in March 2013 that because of the malfunction, barcoded stickers for Veracruz were 
being printed in Puebla, a neighboring state. As a result, it took more than a month from 
the time new stickers were requested until they could be picked up.139 
 
Under the announced reforms to the prescribing system for this class of medicines, the 
government plans to institute an electronic process for barcoded stickers. Physicians will be 
able to request 100 sets of barcoded stickers at a time, download these onto their computers 
and print them.140 Provided the electronic system works smoothly, it should eliminate most 
of the difficulties physicians currently encounter in obtaining barcoded stickers. 
 
Licensing of Pharmacies 
Under Mexican regulations, pharmacies must obtain a special license to be able to buy 
and sell opioid medications and they must keep detailed books of any sales.141 We 
interviewed about a dozen managers of pharmacies, who had obtained this license or were 
in the process of doing so, and they described the process as relatively unproblematic. 
They said obtaining the license did require a certain amount of paperwork and that it can 
take several months to receive final approval but that was not overly complex. They also 
said that record keeping requirements are more stringent than for regular medications, 
although they did not consider that to be a significant problem.142 
 
In contrast, about a dozen managers and other staff of pharmacies who did not have the 
license often cited the perceived hassle of carrying opioid analgesics. They said that it would 
be difficult to get the license, that the paperwork involved in accounting for the comings and 
                                                          
138 Email correspondence with Dr. Argelia Lara, April 7, 2014. 
139 Email correspondence with Dr. Rafael Contreras Bello, March 6 and 25, 2013. 
140 Human Rights Watch meeting with Mikel Arriola-Peñalosa, commissioner of COFEPRIS, September 3, 2014. 
141 See Suplemento, chapters VII and XV.  
142 Human Rights Watch interviews with managers of pharmacies in Guadalajara, Jalisco, and Tuxtla-Gutiérrez, Chiapas.  
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goings of these medicines would be cumbersome, and that they would be subject to 
additional and invasive inspections by officials of their management of opioid analgesics. 
 
But the main reason these pharmacy staff identified for not getting the license was the lack 
of demand for these medicines. The manager of a pharmacy in Tepatitlán, Jalisco, for 
example, told us: “It doesn’t make economic sense. We can’t return these medicines so 
they will expire. People don’t request the medicines.”143 Given how few physicians 
prescribe these medicines, especially outside of the major cities, this is hardly surprising. 
 
Several pharmacists identified the fact that they must provide the state health department 
with a projection for the amount of opioid analgesics they expect to need for a six month 
period as a problem. They said that if it turns out during that period that they need more of 
a certain medication they have to wait for the next six month period to adjust their 
estimate.144 As a result, pharmacies may run out of the medication, which can be difficult 
for patients as so few pharmacies carry opioid analgesics. 
 
Problems with Dispensing of Opioid Analgesics 
 
How often do patients have to return to get a new prescription? All the time! 
– Pharmacy manager in Guadalajara145 
 
Easily 15% of my barcoded stickers are lost…Why is it so difficult? It's hard 
for the doctor, hard for the patient and hard for the pharmacy. It should be 
much simpler – Dr. Jesús Medina146 
 
In interviews with patients, family members, physicians and pharmacists we heard dozens 
of reports of pharmacies refusing to fill prescriptions for opioid analgesics because of 
errors or non-compliance with official rules. Some physicians estimated that pharmacies 
cannot fill as many of 15 to 30 percent of the prescriptions they write for opioid analgesics. 
 
                                                          
143 Human Rights Watch interview with manager of Buenavides pharmacy in Tepatitlán, February 24, 2012. 
144 Suplemento, chapter XV. 
145 Human Rights Watch interview with the manager of a pharmacy in Guadalajara, February 21, 2012.  
146 Human Rights Watch interview with Dr. Jesús Medina, Guadalajara, November 16, 2011. 
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These refusals are major inconveniences for people with life-limiting illnesses and their 
relatives. When a pharmacy cannot fill their prescription they have to return to their 
physicians for a new prescription. Such a trip—followed by a second trip to the pharmacy—
can take many hours and may temporarily leave the patient without their medicines. For 
doctors, rejected prescriptions are a problem because they lead to a waste of barcoded 
stickers that, as described above, are hard to get. 
 
We found that the rejection of these prescriptions is generally due to a combination of 
factors, including limited and unreliable stock of these medicines at pharmacies, 
excessive caution in handling this class of medicines at some pharmacies, inspections by 
departments of health that sometimes appear to encourage this, and finally, a lack of 
flexibility in the prescribing and dispensing rules that would allow for the problem to be 
resolved without an extra trip to the physician. 
 
Most of the rejections of prescriptions we learned about were related to one of the 
following requirements: 
 
• The requirement that the prescription covers a period of no more than thirty days;147 
 
• Challenges with correcting minor, technical errors on prescription forms for opioid 
analgesics by pharmacies;148 
 
• The requirement that prescriptions for opioid analgesics contain both the 
commercial and generic name of the medicine;149 
 
• The lack of authority for pharmacies to substitute the medicine or formulation 
indicated in the prescription form, even after consultation with the prescribing 
physician, if they are out of stock of the requested medicine.150 
 
                                                          
147 See Sección B. Requisitos Para El Surtido de Recetas, Capítulo XV: Medicamentos Controlados, Suplemento. 
148 Chapter XV of the Suplemento allows the person in charge of the pharmacy (in Spanish: responsable sanitario) to make 
corrections to prescriptions after requesting clarification from the prescribing physician. However, it is common that the 
person in charge is not at the pharmacy and the regulations do not allow regular pharmacy staff to make corrections. 
149 See: Sección E. Formato del Recetario Especial, Capítulo XIV: Receta Médica, Suplemento; and Article 31 of the 
Reglamento de Insumos para la Salud, available at http://www.salud.gob.mx/unidades/cdi/nom/compi/ris.html (accessed 
July 11, 2014). 
150 Ibid. 
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In a meeting with Human Rights Watch in September 2014, Mikel Arriola, the head of 
COFEPRIS, agreed to make two key changes to the prescribing rules, which could help 
avoid many of the cases of canceled prescriptions we documented.151 He also agreed that 
COFEPRIS would hold periodic meetings with the pharmaceutical industry, pharmacies and 
prescribers to try to identify potential challenges with the supply of morphine so as to 
avoid stock-outs. 
 
Compliance with the 30-day Prescription Limit  
 
…at times you have to invent things: the dose, the number of tablets so that 
they don’t return them [the prescriptions]. – General practitioner152 
 
Mexican prescription rules for opioid analgesics limit the number of days a prescription for 
such medicines may cover to thirty days.153 This limitation is not unreasonable. Indeed, 
most countries in the region impose a similar limit, although a few countries—Belize, 
Paraguay, St Lucia and Uruguay—leave it to the discretion of the prescriber.154 
 
Yet, this limit creates a number of significant problems in Mexico because pharmacies only 
dispense ready-made packages of medications. In other words, pharmacies do not count 
out the exact number of tablets or ampoules indicated on the prescription form but sell 
pre-packaged units.155 Current practice is that if the amount of medication in a package 
exceeds the amount prescribed for the thirty days period, the pharmacy cannot dispense. 
 
The amount of medications a patient needs over a 30 day period often does not coincide 
with the contents of available prepackaged boxes.156 For example, Dr. Carlos García, a 
general practitioner in Ajijic, Jalisco, told us: “If the box comes with 100 tablets but the 
                                                          
151 Human Rights Watch meeting with Mikel Arriola-Peñalosa, September 3, 2014, México City. 
152 Human Rights Watch interview with a general practitioner who requested to remain anonymous. 
153 See Sección B. Requisitos Para El Surtido de Recetas, Capítulo XV: Medicamentos Controlados, Suplemento.  
154 Jim Cleary et al., “Formulary Availability and Regulatory Barriers to Accessibility of Opioids for Cancer Pain in Latin 
America and the Caribbean: A Report from the Global Opioid Policy Initiative (GOPI),” Annals of Oncology 24 (2013): xi41–
xi50, accessed July 11, 2014, 2013, doi:10.1093/annonc/mdt502. 
155 Most pharmacies in México do not employ anyone with training in pharmacy. 
156 It is accepted practice for physicians to include rescue doses in prescriptions for opioid analgesics, which can be used 
when a patient experience pain that is not controlled by the prescribed dose. When the amount of excess medication is small, 
physicians generally designate the leftovers as rescue doses. 
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patient only needs 60 they won’t sell you the prescription.”157 Physicians told Human 
Rights Watch that this forces them to revert to trickery to be able to prescribe the 
medications. One pain specialist, who requested anonymity because of potential legal 
implications, said: “I can't leave my patients without medications. So I fill out the 
prescription as if it would end in 30 days even though I know it will last him [longer]...158 
 
Many doctors said they give patients two prescriptions: One (on the official prescription 
form with bar coded sticker) that has fictional daily doses of the medication adjusted to 
fulfill regulatory requirements and used only to get the medications from the pharmacy; 
the other (on a separate regular prescription form) with actual instructions to the patient 
on the doses and frequency with which the medications should be taken. One doctor gave 
the following example: 
 
Sometimes patients require just a little more than 100 [tablets]…say 120 
tablets per month. To give them 120 tablets I have to prescribe two boxes of 
100 tablets and invent that they have to take more [six per day instead of 
four]. Otherwise, they won’t give [the medication] to them. Imagine, if I 
need 120 tablets that means I’ll have 80 left over. So we’re complying with 
the rule. The rule isn’t violated. But sometimes the rule is so inflexible that 
it obliges one to do things like this.159 
 
A system that forces physicians to write prescriptions that do not correspond to the actual 
dosage prescribed for the patient is obviously problematic, especially as it can lead to 
confusion among patients and their families regarding the instructed dosage.  
  
 
 
 
 
 
                                                          
157 Human Rights Watch interview with Carlos García, November 11, 2011, Chapala, Jalisco. 
158 Human Rights Watch interview (name is withheld at the request of the physician). 
159 Human Rights Watch interview (name is withheld at the request of the physician). 
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Table 4. Oral opioid formulations160   
Medication Brand name Formulation Tablets per package 
Hydromorphone Liberaxim 2mg 100 tablets 
Methadone Rubidexol 5mg 100 tablets 
 10mg 100 tablets 
 Amidone 40mg 100 tablets 
Morphine Analfin 10mg 20 or 100 tablets 
 15mg 20 or 100 tablets 
 30mg 20 or 100 tablets 
Graten 30mg 20 or 100 tablets 
Oxycodone (immediate 
release)  
Endocodil 5mg 
10mg 
20mg 
40mg 
15, 30, or 100 tablets 
15, 30, or 100 tablets 
15, 30, or 100 tablets 
15, 30, or 100 tablets 
Oxycodone (w paracetamol) Plexicodim 5mg/325mg 100 tablets 
Oxycodone (extended 
release) 
Oxycontin 10mg 
20mg 
40mg 
30 tablets 
30 tablets 
30 tablets 
 
Commercial and generic names. The rules for special prescription forms do not directly 
require that the physician indicate both the generic and commercial name of the opioid 
analgesic.161 However, the rules for health supplies determine that for medicines not 
included in Mexico’s catalogue of generic medicines—and none of the opioid analgesics 
are—it is obligatory that the commercial name of the medicine be indicated on the 
prescription form.162 The rules establish furthermore that when the prescription contains 
the commercial name of the medicine the pharmacy can only dispense that denomination 
and “may only substitute it when expressly authorized by the prescriber.”163 
                                                          
160 Information obtained from COFEPRIS’ medicines database at 
http://189.254.115.245/BuscadorPublicoRegistrosSanitarios/BusquedaRegistroSanitario.aspx (accessed July 16, 2014). 
161 Sección E. Formato del Recetario Especial, Capítulo XIV: Receta Médica, Suplemento. 
162 Article 31 of the Reglamento de Insumos para la Salud, available at 
http://www.salud.gob.mx/unidades/cdi/nom/compi/ris.html (accessed July 11, 2014). 
163 Article 31 of the Reglamento de Insumos para la Salud states: “The person who issues the prescription shall prescribe the 
medicines in accordance with the following: 
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As a result of these rules, pharmacies refuse to dispense opioid analgesics if the commercial 
name of the medicine is not indicated in the prescription. Similarly, they are not allowed to 
dispense alternatives of the same medicine with a different commercial name, even if they 
consult with the prescribing physician. For example, if a patient has a prescription for 
morphine tablets under the commercial name Graten (produced by PISA Pharmaceuticals) 
but the pharmacy has only Analfin (morphine tablets produced by Tecnofarma) it cannot 
dispense the morphine when the dosage and formulation are the same. 
 
Miguel Márquez, the brother of Alejandra, said that morphine had recently run out in 
various pharmacies in Guadalajara.  
 
Right now there isn’t any in Farmacias Guadalajara or in Benavides [another 
pharmacy], only in Farmacias Especializadas. They have to sell them. It's 
necessary. This is for a pain that is sharp. It's as I said sometimes the pain 
hits her it can be for four hours and she cries and screams.164 
 
While these rules were clearly not intended to complicate access to opioid analgesics, 
both doctors and patients told us this is a significant issue for them. The problem is 
particularly acute because pharmacies maintain limited stock of opioid analgesics due to 
the limited use of these medicines in Mexico and the fact that supply is not always reliable. 
As a result, pharmacies frequently run out of stock of certain medicines and/or 
formulations. 
 
In the above-mentioned meeting with Human Rights Watch, COFEPRIS agreed to a change 
in prescription rules to allow physicians to indicate only the active substance (or generic 
name) on prescription forms as opposed to the commercial name.165 
 
                                                                                                                                                                             
I. In case the medicines are included in the Catalogue of Interchangeable Generic medicines, referred to in article 75 of this 
order, he shall note the generic denomination and, if so desired, he can indicate the specific denomination of his preference; 
and 
II. In case of medicines that are not included in the catalogue referred to in the previous provision, he shall equally include 
the specific denomination or jointly the generic and specific denomination. 
When the prescription indicated the specific denomination of the medicine the sale or application must be agree exactly with 
this denomination and can only be substituted when expressly authorized by the prescriber.” 
164 Human Rights Watch interview with Esmeralda and Miguel Márquez (pseudonyms), November 12, 2011, Guadalajara. 
165 Human Rights Watch meeting with Mikel Arriola-Peñalosa, September 3, 2014, México City. 
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Lack of flexibility to make technical corrections to prescriptions for opioid analgesics. 
Under current regulations, only the person in charge of pharmacies, the responsable 
sanitario, can correct technical or clerical errors on the prescription after consulting the 
prescribing physician. When this official is not present, which is very common, Mexico’s 
rules do not permit corrections so the patient must return to the physician for a new 
prescription. Errors may include an illegible diagnosis, a mistake in the spelling of the 
name of the patient, or an error in the formulation of the medication (for example, 50mg 
tablets of methadone, which do not exist in Mexico, instead of 5mg). A doctor at a pain 
clinic in Guadalajara, for example, said:  
 
There are pharmacies that are very over sensitive. If I put Sector Libertario 
[a neighborhood in Guadalajara] as “SL” or if I put down “GDL” or “GAL” [for 
Guadalajara], they refuse to fill it.166 
 
The WHO recommends that “in order to start the prescribed therapy in a timely manner, 
legislation should address the pharmacist’s ability to correct technical errors in 
prescriptions.”167  
 
Substituting formulation of medication. Under current rules, there is no mechanism to 
adjust the formulation of opioid analgesics when the formulation indicated on the 
prescription form is not available. Thus at present, a pharmacy would not be able to 
dispense 10mg morphine tablets to a patient with a prescription for 30mg morphine 
tablets even if the latter are unavailable. Patients told us that as stock is often limited and 
few pharmacies carry opioid analgesics, which is frequently a problem. At present, even a 
faxed or emailed correction from the prescribing physician is not sufficient to allow the 
pharmacy to substitute the formulation. Dr Jesús Medina of Instituto Palia told Human 
Rights Watch: “Patients often return. They say: ‘Doctor, this medication is out. They don't 
have it in the pharmacy. They only have this strength. What do I do?’ ‘Doctor, can you write 
a new prescription?’”168 
 
                                                          
166 Human Rights Watch interview with Dr. Gerardo Rodríguez, November 16, 2011, Guadalajara. 
167 WHO, “Ensuring Balance in National Policies on Controlled Substance: Guidance for Availability and Accessibility of 
Controlled Medicines,” http://whqlibdoc.who.int/publications/2011/9789241564175_eng.pdf?ua=1, p. 30. 
168 Human Rights Watch interview with Jesús Medina, November 16, 2011, Guadalajara. 
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During the above-mentioned meeting, the head of COFEPRIS suggested that prescription 
rules could be changed to allow physicians to indicate multiple alternatives for dosages on 
prescription forms.169 In other words, physicians would be able to indicate that the 
pharmacist could dispense tablets of 30mg or twice the number of tablets of 15mg. Such 
change to the rules would greatly facilitate the dispensing of these medicines.  
 
Some pharmacists told us that inspections by the health department had made them more 
cautious about dispensing opioid analgesics. For example, the manager at Farmacia 
Maypo in Guadalajara said the health department had criticized him for dispensing a 
prescription for one hundred tablets of morphine that did not specify whether it should 
consist of one box of one hundred tablets or five boxes of twenty. The manager said:  
 
We did not have that kind of control before. Before, you could say: “Here 
you go” when you got that kind of prescription. Since they came, we [reject] 
prescriptions more frequently.170 
 
The manager of another pharmacy told us: “There are complaints because of the 
formulations. They fine us. With controlled medicines, there is no flexibility. They are very 
strict.”171  
 
                                                          
169 Human Rights Watch meeting with Mikel Arriola-Peñalosa, September 3, 2014, México City. 
170 Human Rights Watch interview with the manager of Maypo Farmacias, February 20, 2012, Guadalajara. 
171 Human Rights Watch interview with the manager of a pharmacy, February 21, 2012, Guadalajara. 
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Stock-Outs of Morphine 
Medical doctors from each of the regions where we conducted research said they 
frequently faced stock-outs of opioid medicines. A palliative care doctor from 
Chiapas said, for example: “Stock-outs of morphine are a key factor that limits our 
use [of the medicine].”172 To obtain a snapshot of current stock-outs, we surveyed 
palliative care physicians and pharmacists at institutions in Chiapas, Jalisco, Nuevo 
León and Mexico City who told us the following about stock-outs they had 
experienced in 2014.  
 
Jalisco: “At this moment we have a stock-out of morphine in tablets in the 
metropolitan area [of Guadalajara]. We don’t have tablets of 15 and 30mg of either 
brand. There are just a few boxes of Analfin [one of the brands] with 20 tablets of 
10mg left. This has been going on for two weeks and according to the representative 
[of Tecnoforma, which produces Analfin] we won’t have [a new supply of morphine] 
until mid-September.”173 
 
Mexico City: “In April and May, we were altogether without morphine. Now there are 
tablets of 10mg but not of 15 or 30mg. I currently have a patient with advanced 
cancer for whom taking three times as many tablets is difficult because she has 
trouble swallowing. My only alternative is to prescribe Oxycodone, which is 
available, but six times more expensive.”174 
 
Nuevo León: “We have not had difficulties with oral morphine in Monterrey but 
recently we’ve had a stock-out of injectable morphine. I currently have a patient with 
cancer who needs high doses of morphine and I have to switch her to different 
opioids because the pharmacy has been informed that they won’t get any more 
[stock in the immediate future].”175 
                                                          
172 Email correspondence with Dr. José Antonio Córdova Domínguez, July 23, 2014. 
173 Email correspondence with Alan Ruiz, pharmacist at Instituto Palia, July 21, 2014. 
174 Telephone interview with Dr. Argelia Lara of Hospital Nutrición, July 25, 2014. 
175 Email correspondence with Dr. Víctor Silva of Centro Médico Zambrano Hellion, July 23, 2014. 
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Chiapas: “Pharmacies do not have stock of the different formulations or continuity 
of stock over time. This means we cannot maintain effective pain therapy over 
time.”176  
 
We did not specifically investigate the reasons for these stock-outs although 
interviews suggest they are likely caused by a combination of factors, including lack 
of demand for these medicines, the limited number of pharmaceutical companies 
producing them, regulatory complexities around the importation of raw materials, 
inadequate communication, and problems with compliance with regulations on 
handling opioid materials. On September 12, 2014, COFEPRIS and Mexico’s member 
of the International Narcotics Control Board, Dr. Alejandro Mohar-Betancourt, hosted 
a first meeting of pharmaceutical companies, pharmacies and healthcare providers 
to identify and overcome challenges with the supply of morphine.177 
 
Barriers to Access to Opioid Analgesics in Home Care 
While Mexican law encourages home-based palliative care current regulations do not 
authorize physicians who conduct home visits to patients to carry opioid analgesics.178 
Under current regulations home teams should leave families with prescriptions so that a 
family member can go to the pharmacy to buy the medications. This seems to defeat the 
purpose of home-based palliative care. 
 
Some home teams have developed a trick that allows them to bring medications with them 
and leave them with the patients. As regulations allow people to carry opioid medications 
if they have a filled out prescription form with barcoded sticker, these home-care 
physicians write a fictitious prescription for opioid analgesics, with barcoded stickers, 
before they head out to visit patients in their homes. This prescription allows them to carry 
the medicines. At patients’ homes, they conduct an examination in order to determine the 
                                                          
176 Email correspondence with Dr. José Antonio Córdova Domínguez, July 23, 2014. 
177 A Human Rights Watch researcher participated in the meeting. 
178 Section III of the Reglamento de Insumos para la Salud (the Regulation on Medical Supplies) regulates how narcotic drugs 
and psychotropic substances may be handled. It does not make any provision for home-based palliative care teams to carry 
opioid medicines. Available at http://www.salud.gob.mx/unidades/cdi/nom/compi/ris.html (accessed on July 24, 2014). 
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dosage the patient actually needs at which point they may need to write another 
prescription for the actual amount of medication the patient requires. 
 
The existence of these restrictions is not surprising. Drug regulations in most countries 
were written before the home-based and primary-care models for palliative care began to 
develop. Regulations, however, need to be modernized to reflect current needs and 
practices. Just as Mexican regulations authorize—indeed oblige—certain ambulances to 
carry injectable morphine, they should specifically allow home-based palliative care teams 
to bring supplies of opioid medicines to their patients without having to waste prescription 
forms.179 
 
Inclusion of Essential Palliative Care Medicines in Mexico’s Medicines’ Lists 
Since 2013, the WHO Model List of Essential Medicines contains a section on pain and 
palliative care that includes a total of twenty medications in three categories: non-opioids 
and non-steroidal anti-inflammatory medicines, opioid analgesics, and medicines for other 
common symptoms in palliative care patients. The WHO recommends that these medicines 
be available to all who need them in the formulations indicated in the list. The May 2014 
World Health Assembly resolution recommends that all countries adjust their national 
medicines lists accordingly. 
 
In Mexico, the Council of Public Health (Consejo de Salubridad General) is responsible for 
preparing and updating the list of essential medicines (in Spanish: Cuadro Básico y 
Catálogo de Medicamentos). This list forms the basis of the medicines lists of Mexico’s 
health insurers, such as Seguro Popular and IMSS.180 The list was last updated in 2013. 
 
A comparison of the WHO’s list and the medicines lists of the Council, Seguro Popular and 
IMSS reveal a number of important differences (see Appendix 2), including:181 
                                                          
179 Norma Oficial Mexicana, NOM-237-SSA1-2004, Regulación de los servicios de salud. Atención prehospitalaria de las 
urgencias médicas. (Regulation of Health Services. Pre-hospital attention for medical emergencies, see Appendix normativo 
C. Available at http://www.salud.gob.mx/unidades/cdi/ (accessed on July 25, 2014). 
180 “Cuadro Básico y Catálogo de Medicamentos del Consejo de Salubridad General,” undated,  
http://www.cofepris.gob.mx/MJ/Documents/AcuerdosConsejoSalubridadGeneral/250214csgmedicamentos.pdf (accessed 
on September 16, 2013).  
181 The Universal Catalogue of Health Services (Catálogo Universal de Servicios de Salud) of March 2014 is on file with 
Human Rights Watch. “Cuadro Básico de Medicamentos del Instituto Mexicano del Seguro Social,” undated, 
http://www.imss.gob.mx/sites/all/statics/pdf/cuadros-basicos/CBM.pdf (accessed on September 16. 2013). 
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• None of the Mexican lists contain a pain and palliative care section. Instead, as in 
earlier versions of the WHO’s list, palliative care medications are spread out over 
six different sections, including analgesia, anesthesia, psychiatry, rheumatology, 
gastroenterology and oncology. As a result, medicines that may be needed for the 
provision of palliative care to a patient with heart disease may be categorized as 
medicines for cancer or psychiatry. This may lead to reluctance among physicians 
to prescribe these medicines. 
 
• Five medicines that the WHO considers essential for palliative care are not 
included in any of Mexico’s lists: docusate sodium, cyclizine, hyoscine 
hydrobromide (on the WHO Model List of Essential Medicines for Children), 
ibuprofen, and lactulose. According to a Mexican pharmacist specialized in 
palliative care, Mexico’s lists do not contain an adequate substitute for the first 
three of these medicines.182 
 
• Key formulations, mostly oral solutions and suppositories, for eight medicines on 
the WHO list are missing from Mexico’s lists.183 This complicates administration to 
patients who have trouble swallowing or have uncontrollable nausea, neither of 
which is uncommon in palliative care patients. Oral solutions are also essential for 
many young children. 
 
• Finally, Mexico’s essential medicines lists specify at what levels of care medicines 
should be available whereas the WHO recommends that all essential medicines be 
available at all levels of care.184 The Council’s list, for example, designates six of 
the essential palliative care medicines—opioid analgesics, several medicines 
                                                          
182 Email communication with Raymundo Escutia, head of the department for inter-hospital networking at the Jalisco mental 
health institute, secretary of the Iberian and Latin American Organization of Pharmacists and former head of pharmacy at 
Instituto Palia. Metamizol is an adequate substitute for ibuprofen and plantago psyllium can be used as a substitute for 
lactulose. 
183 These are: suppositories of ácido acetilsalicílico, oral solution of metamizol (ibuprofeno), oral solution of morphine, 
Gránulos de morfina, oral solution of dexametasona, rectal solution of of Diazepam, oral solution of midozalam, and oral 
solution of ondansetron. 
184 See explanatory note to the WHO Model List of Essential Medicines of April 2013, October 2013, 
http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1 (accessed July 11, 2014). 
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routinely used in patients with anxiety, and an anti-nausea medicine—for use only 
in secondary and tertiary care facilities. 
 
These discrepancies are likely to lead to inadequate treatment for patients who require 
palliative care.   
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IV. Mexico’s Legal Protections for Patients in Need of 
Palliative Care 
 
In 2009, Mexico enacted a series of amendments to its health law to better address the 
healthcare needs of people with terminal illnesses. The amendments pursued several 
objectives, including: 
 
• To ensure the dignity of people in the terminal stages of disease through the 
necessary medical care to maintain their quality of life; 
• To ensure a natural death in dignified circumstances; 
• To establish and guarantee the rights of the person in terminal state with respect to 
his treatment; 
• Determining the limits between the protection of life and futile care (in Spanish: 
obstinacion terapeutica).185 
 
They set out a series of rights of people with terminal illness and their families, as well as 
powers and obligations of health institutions and healthcare personnel. In 2013, the 
government issued additional regulations, a reglamento, that clarifies and elaborates on 
the amendments.186 
 
The amendments explicitly only apply to people with a prognosis of less than six months, 
rather than to all people who require palliative care. In this respect, Mexico’s law falls 
short of WHO’s recommendation that people with life-limiting illnesses receive palliative 
care from the time of diagnosis.187 As a result, as Mexican Supreme Court Justices José 
Ramon Cossío Díaz and José Fernando Franco González-Salas note in a recent article, 
people with a diagnosis of more than six months who suffer severe pain are “completely 
                                                          
185 Article 166 Bis 13 of the health law. For a detailed analysis, see a publication by Supreme Court justices José Ramón 
Cossío Díaz and José Fernando Franco González-Salas et al in Gaceta Médica de México. José Ramón Cossío Díaz et al, 
Regulación de los cuidados paliativos y muerte asistida (Regulation of palliative care and supported death), Gaceta Médica 
de México [in print].  
186 “Diario oficial mexicano,” November 1, 2013, 
http://www.diputados.gob.mx/LeyesBiblio/regley/Reg_LGS_MPSAM_ref02_01nov13.doc (accessed on June 27, 2014). 
187 Under the WHO definition, palliative care should be provided not just to terminal patients but to all patients with life-
limiting illnesses irrespective of their prognosis. WHO, “WHO Definition of Palliative Care,” 2014, 
http://www.who.int/cancer/palliative/definition/en/ (accessed on June 27, 2014). 
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unprotected.”188 Mexico’s health law does establish that “integral treatment of pain” is a 
general objective of the health system, irrespective of diagnosis or prognosis and pain is 
defined broadly as including physical and mental pain.189 However, the law does not 
provide any specifics on how this objective should be operationalized.190 
 
Table 5 - Rights Accorded to Persons in Terminal Stages of Illness under Mexico’s General 
Health Law 
Access to Health Services Right of Autonomy  
Receive integral health services. Receive clear, opportune and sufficient 
information about his illness and treatment 
options. 
Be admitted to a health institution; Receive 
outpatient and inpatient attention. 
Give informed consent in writing for the use or 
non-use of treatment, medicines or palliative 
care appropriate for his illness, needs and 
quality of life. 
To leave voluntarily.  Assign a legal representative or person of 
confidence for in case the ability to express his 
wishes is lost. 
To receive dignified, respectful and 
professional treatment that aims to preserve 
quality of life. 
Formulate advanced directive which must be 
respected; revoke the advanced directive. 
To request that the physician administers 
medicines to relieve pain. 
Renounce, abandon, or refuse at any moment 
to receive or continue treatment considered 
extraordinary. 
To choose to receive palliative care in a private 
home. 
Voluntarily suspend curative treatment. 
To receive spiritual care. Request that curative care be re-initiated. 
 
While the legislator left decisions on the specifics of the implementation of the 
amendments to the health ministry, the law sets out in broad terms a vision for integration 
of palliative care into the healthcare system, very much in line with Mexico’s international 
                                                          
188 José Ramón Cossío Díaz et al., p. 6. 
189 Article 3 XXVII Bis. 
190 José Ramón Cossío Díaz et al., p. 11. 
  91 HUMAN RIGHTS WATCH | OCTOBER 2014 
human rights obligations and the recommendations by WHO and WHA. Among others, the 
following broad obligations flow from the law: 
 
• Palliative care must be integrated into the healthcare system. Health care providers 
have an obligation to offer palliative care to patients with terminal illness and a 
prognosis of six months of life or less; 
• Healthcare institutions must ensure that staff are appropriately trained in the 
provision of palliative care; 
• Medicines required in the provision of palliative care for treatment of pain and 
other symptoms must be available. 
 
The amendments instructed the health ministry to issue the “regulations and official 
Mexican norms that are required to guarantee the exercise of the rights contained in this 
title” within 180 days.191 As noted, in December 2013, the ministry issued the regulations 
but the official norm (Norma Oficial Mexicana) has still not been issued. In absence of that 
norm, as Justices Cossío and Franco note, this is an “obstacle for the standardization of 
the services because the necessary parameters for clarifying what resources—human and 
material—a specialized palliative care unit requires are absent.”192 The publication of the 
official norm is expected in October 2014.193  
 
Obligation to Offer Palliative Care Services 
The rights articulated in the law and regulation (see Table 5) are broad and sweeping 
enough that they can only be realized if all healthcare institutions in Mexico have 
personnel that offer palliative care. Indeed, the text of the palliative care chapter of the law 
suggests strongly that it requires all institutions of Mexico’s national healthcare system to 
offer this health service. 
 
The law states, for example, that institutions of the national healthcare system “offer 
appropriate attention to patients with terminal illness” and “provide palliative care 
corresponding to the type and grade of the illness from the moment the terminal illness is 
                                                          
191 Diario Oficial of January 5, 2009. 
192 José Ramón Cossío Díaz et al., p. 12. 
193 Human Rights Watch meeting with Dr. Sebastián García Saisó, director of the Department for Quality and Education in 
Health, Ministry of Health, September 4, 2014. 
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diagnosed until the last moment.”194 The law does not provide for any exceptions or for 
mechanisms that would allow institutions that do not have palliative care to refer patients 
to healthcare institutions that do. 
 
The law, however, is vague on how exactly healthcare institutions should offer palliative 
care, seeming to suggest a significant level of discretion on the part of the institutions. It 
states that institutions should “promote the creation of specialized areas that provide 
attention to patients with terminal illness.”195 The regulation adds that healthcare 
institutions “shall have the infrastructure, suitable personnel, adequate material and 
technological resources for medical attention in palliative care in accordance with the level 
of complexity, the decision making power, the availability of financial resources, 
organization and functionality.”196 In some places, the regulation appears less categorical 
than the law, referring to “institutions that provide these services.”197 Both the law and 
regulation are silent on accountability for implementation of the legal requirements under 
the law. 
 
The law and regulation furthermore do not address the role of primary care providers in 
palliative care, referring only to the obligations of specialists at secondary and tertiary care 
institutions in providing the service.198 Primary care providers, however, will need to play 
an essential role in caring for patients who spend their last weeks or months at home. 
Justices Cossío and Franco comment that the focus in the legislation on secondary and 
tertiary level institutions is “not the most well-suited for opening access to these services 
as the patient has to move to these institutions” which normally are located only in major 
cities. They recommend considering that the legal context should “incentivize the 
participation of institutions of the primary level…This way, palliative care would be within 
reach of more people…”199 
 
                                                          
194 Article 166 Bis 13 (I and IV) of the health law. In accordance with article 50 of the health law, the national healthcare 
system includes public, social and private healthcare providers. 
195 Article 166 Bis 13 (V) of the health law. 
196 Article 138 Bis 12 of the 2013 regulation. 
197 Article 138 Bis 3, 138 Bis 12, 138 Bis 17 of the regulation. 
198 Article 166 Bis 15 of the health law. 
199 José Ramón Cossío Díaz et al., p. 12. 
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Home-based Palliative Care 
 
Yes, it is possible to attend to a [dying] patient at home but only with good 
guidance. This would save the social insurance in care and cost. But they 
have to provide all that is needed to allow for care at home. – Adriana Lucía 
Preciado Santana200  
 
The law states that patients with terminal illness have the right to “opt to receive palliative 
care in a private home,” an important right given that many people prefer to die in their 
own homes surrounded by relatives.201 The law and regulation, however, are not clear on 
how exactly home-based palliative care is to be delivered and whether healthcare workers 
would visit the homes of patients who opt to exercise this right. 
 
The relevant provisions of the law and regulation focus more on healthcare workers 
facilitating care at home than on actually providing the care. The law, for example, states 
that healthcare institutions must “[p]rovide services of orientation, advice and follow-up” 
to patients and their families if palliative care “is realized in a private home.”202 The 2013 
regulation specifies that as part of the palliative care plan, the treating physician must 
“consider those actions that need to be undertaken in the home of the patient in terminal 
stage by family members, caregivers or volunteers.”203 It also instructs members of the 
multidisciplinary palliative care team to offer “training to family members, caregivers and 
volunteers who will be in charge of attention and basic home care for the patient in 
terminal phase.”204 
 
The law and regulation also oblige the ministry of health to put in place a free phone line to 
offer orientation, advice and follow-up to patients in terminal phase of illness, who opt to 
receive palliative care at home, as well as their family members or confidante.205 The 
                                                          
200 Human Rights Watch interview with Adriana Lucía Preciado Santana, February 22, 2012, Guadalajara. 
201 Article 166 Bis 3 (IX) of the health law. 
202 Article 166 Bis 13 (II) of the health law. 
203 Article 138 Bis 15 of the 2013 regulation. 
204 Ibid. 
205 Article 166 Bis 13 (III) of the health law. 
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regulation adds that the health ministry must be “expeditious, attentive and respectful 
and sufficient to satisfy the needs for information of the person who calls.”206 
 
In their article on the palliative care amendments, Justices Cossío and Franco call the right 
to opt for home-based palliative care “a significant challenge” for health care providers 
because it “requires realizing various activities outside the facilities where they normally 
work.” They also note that offering care at home is “an important step” in realizing the 
legislation’s objective to ensure people with a terminal illness can die in dignified 
conditions.207 
 
Training of Healthcare Workers 
The law and regulation clearly determine that health personnel must have adequate 
training in palliative care. The law holds, for example, that “treating physicians and the 
health team that offer palliative care…must be adequately trained humanly and technically 
by institutions authorized to do so.”208 To ensure such training the law stipulates that 
healthcare institutions must “guarantee the training and continued education of human 
resources in healthcare in the area of palliative care and attention to patients in terminal 
phase."209 The regulation specifies that healthcare institutions must “seek to ensure that 
the training and continued education of professionals, technical, and auxiliary health staff 
in the area of palliative care is conducted at least once per year.”210 Justice Cossío and 
Franco call the law’s provisions on training a “great challenge” as they require “availability 
of trained personnel throughout the republic.”211 
 
The law, however, does not provide any guidance on what institutions and individuals are 
authorized to conduct such trainings, the contents of the trainings, or offer any 
accountability mechanisms. The law is furthermore silent on the integration of palliative 
                                                          
206 Article 138 Bis 16 of the 2013 regulation. 
207 José Ramón Cossío Díaz et al., p. 7. 
208 Article 166 Bis 14 of the health law. 
209 Article 166 Bis 13 (VI) of the health law. 
210 Article 138 Bis 12 of the 2013 regulation. 
211 José Ramón Cossío Díaz et al., p. 10. 
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care education into the curricula for students of medicine, nursing, psychology, and social 
worker—an essential step without which implementation of the law will fail.212  
 
Access to Medicines  
Mexico’s health law and the regulation on palliative care clearly require that essential 
palliative care medicines be available and accessible. The 2013 regulation explicitly states 
that health institutions “must have a sufficient supply of pharmaceutical and supplies for 
the management of pain of the patient.”213 The regulation does not determine what is 
considered a “sufficient supply.” These kinds of determinations are generally included in 
Mexico’s official norms.  
  
                                                          
212 México does not have a centralized system for certification of professionals, such as medical doctors and nurses. This 
complicates standard-setting in professional education as well as setting and enforcing requirements for continuing 
education.  
213 Ibid. 
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V. Making the Palliative Care Law Work 
 
As long as there are no obligations and penalization the law remains nice 
words. The law is great but it does not oblige anyone to do anything…it is 
no more than a romantic notion – Dr. Guillermo Aréchiga, November 2011.214 
 
The adoption of the 2009 changes to Mexico’s health law was a major step. With it, Mexico 
clearly determined that palliative care for terminal patients should be an integral part of 
the country’s healthcare services. But putting the law in place was, in many ways, the easy 
part. Weaving palliative care into the DNA of Mexico’s healthcare system is a challenge of a 
different magnitude. To achieve this, strong leadership by the federal and state 
governments and a comprehensive implementation strategy are essential. 
 
It will require a persistent effort to adapt Mexico’s healthcare system for the delivery of 
palliative care and to remove the barriers identified in this report that impede its provision. 
Government agencies, healthcare and health insurance providers, the pharmaceutical 
industry, civil society, academia and other players will need to work in coordination with 
each other to implement the systemic change required to make the vision of the law—that 
no one should have to die in unnecessary suffering—a reality. Without a clear plan of 
action and a coordinated effort, it is highly likely that palliative care will continue to 
develop in a haphazard and fragmented manner and that thousands of Mexicans will 
continue to suffer unnecessarily as a result. 
 
The past year has seen increasingly positive signs that Mexico is ready to embrace this 
challenge. The years 2013 and 2014 have seen a major increase in attention for palliative 
care in Mexican society. Several Mexican civil society groups have taken up the issue as a 
priority while key high level government officials, including the health minister, the head of 
COFEPRIS and a Supreme Court justice, have all publicly underscored the importance of 
implementing the law. In October 2013, the Mexican Health Foundation and Tómatelo a 
Pecho organized an international seminar on palliative care in which key government 
officials, Mexican civil society leaders and international experts discussed the state of 
palliative care in the country and actions to be taken. The Mexican Health Foundation and 
                                                          
214 Human Rights Watch interview with Dr. Guillermo Aréchiga, November 14, 2011, Guadalajara. 
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Tómatelo a Pecho, working closely with Harvard University, have since organized several 
follow-up meetings that included a broad range of actors to discuss specific next steps. At 
the same time, the National Autonomous University of Mexico has convened a number of 
meetings, initiated by former health secretary Juan Ramon de la Fuente, to discuss the 
training of healthcare personnel in palliative care as well as drug regulatory and other 
barriers to the use of opioid analgesics. 
 
These various initiatives and meetings have yielded some important results. In November 
2013, the ministry of health issued an important regulation clarifying a number of 
important normative issues the 2009 legal changes did not resolve.215 In March 2014, 
COFEPRIS announced a decision to introduce an electronic system for licensing physicians 
to prescribe opioid analgesics, issuing barcoded stickers and keeping records.216 That 
same month, Health Minister Mercedes Juan López instructed her ministry to develop a 
national palliative care strategy, asking Dr. Felicia Knaul of the Mexican Health Foundation 
to work with the ministry on this process.217 Furthermore, the National Commission for 
Social Protection in Health, which administers one of Mexico’s largest health insurers, 
Seguro Popular, added a number of key palliative care interventions to its package, which 
previously did not include palliative care for most patients. In mid-2014, the ministry of 
health tasked the department of quality and education in health with improving the 
availability of palliative care and hired an experienced palliative care physician to 
coordinate this work.218 Following an internal review, the Mexican Social Security Institute 
recently announced its intention to strengthen availability of palliative care within its 
system, including psychosocial and spiritual support and access to medicines.219 The 
adoption of the official norm on the implementation of the palliative care section of 
Mexico’s health law is expected in October 2014. Moreover, the Public Health Council 
(Consejo Nacional de Salubridad) is preparing an agreement between different 
government agencies on the development of palliative care. 
                                                          
215 Diario Oficial of January 5, 2009. 
216 For COFEPRIS’ announcement, see: http://t.co/DXLVO444PJ (accessed June 27, 2014). 
217 A representative of the health ministry announced the decision to develop a national palliative care strategy at a 
consultation meeting on palliative care, organized by Fundación Mexicana para la Salud and Tómatelo a Pecho on June 20, 
2014. 
218 Meeting with Dr. Eduardo González, deputy health minister, June 18, 2014, organized by Fundación Mexicana para la 
Salud and Tómatelo a Pecho; Meeting with Dr. Sebastián García Saisó, director of the department for quality and education 
in health, September 4, 2014. 
219 Email correspondence with the office of Dr. Javier Dávila, director of medical services México, October 13, 2014. 
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The implementation of the law will require a progression of actions that address several 
key challenges. First, the normative and conceptual basis for Mexico’s palliative care 
system needs to be finalized. The law and regulation decide many big picture legal and 
conceptual questions but do not offer a specific model for the delivery of palliative care 
and leave a number of legal questions unresolved. Secondly, the healthcare system itself 
needs to be prepared to support and deliver palliative care services. This means that 
palliative care needs to be incorporated into insurance packages and financing structures 
and integrated into educational programs for healthcare workers. Finally, Mexico will need 
to build the delivery system for palliative care by setting up services, training existing 
healthcare workers, and creating referral systems. 
 
Finalizing the Normative and Conceptual Base 
The chapter in the health law and the 2013 regulations offer a partial normative framework 
and set out a broad vision of universal palliative care for patients with terminal illness. 
However, as noted above, the law and regulation also leave a number of major conceptual 
and normative questions unresolved. It is essential that the government, in cooperation 
with the national health system, civil society, and other relevant actors, address these 
conceptual and normative gaps to allow for proper operationalization and implementation 
of an integrated palliative care system. The official norm will be essential in this respect, 
as is the national palliative care strategy the health ministry is currently developing. 
 
Choosing Model(s) of Delivery. The law and regulation are not specific on the model of 
palliative care that should be used, leaving that decision to the ministry of health. The law 
and regulation do set some parameters that the model must meet including the ability to: 
grant patients a right to opt to receive palliative care in their homes; determine that all 
healthcare institutions must offer palliative care; articulate a number of specific 
obligations for healthcare workers of secondary and tertiary care institutions; and 
determine that palliative care must be provided by multidisciplinary teams on the basis of 
a palliative care treatment plan. Different models of palliative care may meet these criteria. 
The official norm and national strategy should address in particular how home-based 
palliative care will be delivered, what role primary care providers will play, and lay the 
groundwork for a functioning referral and counter-referral system. 
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• Role of primary health providers. The law and regulation make no specific 
mention of primary health providers or their involvement in the delivery of 
palliative care. In order to ensure that palliative care is offered as close to the 
home of the patient as possible, an active role for primary health teams is essential. 
The government thus has to determine what role these healthcare workers are to 
play and how they are going to be trained and supported. Effective coordination 
and cooperation between primary health providers and the multidisciplinary 
palliative care teams at secondary and tertiary care facilities that are mandated by 
the law will likely be essential to the successful implementation of a palliative care 
system. 
 
• Home-based palliative care. The law states that patients with terminal illness 
have the right to “opt to receive palliative care in a private home” but it offers little 
guidance on how home-based palliative care is to be delivered apart from 
instructing healthcare workers to train family members in basic care needs. In 
order to ensure effective home-based palliative care, home visits by trained 
healthcare workers for certain groups of patients are essential. The government 
needs to determine who would conduct such visits, who would be eligible for home 
care visits, and ensure the regulations permit home-care teams to carry essential 
palliative care medicines, including opioid analgesics. It will also have to develop a 
system for round-the-clock support for patients at home and their families, via 
telephone, text message and/or video link. Health insurance policies should cover 
these interventions. The national phone number the law envisions is unlikely to 
work effectively unless patients and families can access on-call healthcare workers 
who have access to their files and know their specific situations. 
 
• Referral and counter-referral systems. In order to allow patients to receive 
highest quality palliative care as close to home as possible, it is essential that a 
strong system of referral and counter-referral be developed. As discussed above, 
most patients with life-limiting illnesses receive curative treatment at tertiary or 
secondary care facilities that are far from their homes. A system needs to be put in 
place that allows patients to be referred between levels of care so that they can 
CARE WHEN THERE IS NO CURE 100 
receive palliative care close to home while primary care providers can also refer 
them back to higher level facilities if so required. 
 
• Palliative care for children. The law refers to pediatric palliative care only in 
passing, making it clear that children with terminal illness have a right to this 
health service without providing any detailed guidance. The palliative care needs 
of children differ significantly from those of adults as do the skills required by 
healthcare workers, making it important to develop specific child-friendly models 
for them. These models should address the special needs of children, their parents 
and siblings in terms of communication about the illness, psychosocial needs, 
assessment of pain, and the place of care. 
 
Panama’s National Palliative Care Strategy 
As in Mexico, Panamanian law grants patients a right to receive palliative care.220 It 
requires all hospitals to have palliative care units and charges primary health centers 
with providing palliative care to patients who require it over extended periods of time. 
In 2011, Panama’s health ministry adopted a national palliative care strategy to help 
implement the law.221 
 
The philosophy behind the strategy is that patients should always receive care as 
close to home as possible. It sets out a model that links the different levels of the 
healthcare system so that patients can move easily between them depending on their 
situation. A patient in curative treatment may receive palliative care at the national 
cancer institute but once they are no longer curable they are referred to care by their 
primary care providers. Conversely, a palliative patient with complex symptoms that 
primary health centers are unable to control can be referred to secondary or tertiary 
levels of care. 
 
A key role in this model is assigned to Panama’s regional hospitals, all of which must 
                                                          
220 See article 23 of Law 68 of November 20, 2003, available at: http://www.gorgas.gob.pa/?wpdmdl=2126&ind=1 
(accessed July 9, 2014). 
221 Ministerio de Salud de Panamá, “National Palliative Care Program (Programa Nacional de Cuidados Paliativos),” 2011, 
http://190.34.154.93/rncp/sites/all/files/Cuidados%20paliativos%20(2).pdf (accessed July 9, 2014). 
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have multidisciplinary palliative care teams. These teams not only offer clinical care 
but are also responsible for training healthcare workers at the primary level of care; 
offering them ongoing support in the care for patients; and working with 
nongovernmental groups, such as NGOs and churches, to develop community support 
for palliative care. The multidisciplinary teams are also the link between the different 
levels of care, facilitating referrals up and down the chain. 
 
Overall responsibility for the implementation of the strategy lies with the health 
ministry, which hired a national palliative care coordinator for the purpose. The 
coordinator works closely with a national palliative care commission which consists of 
all the principal players: the social security agency, the University of Panama, the 
national cancer institute, the children’s hospital and Panama’s main hospice and 
palliative care association. 
 
Panama has made significant progress with the implementation of this strategy. Each 
of the country’s regions has a palliative care coordinator and more than half of the 
regions have active palliative care programs. The number of patients receiving 
palliative care has risen steadily, from around 1,000 in 2010 to 2,500 in 2013. Even so, 
challenges remain, especially in remote regions, within the social security system and 
in the provision of palliative care to children.222 
 
Mandating Inclusion of Palliative Care in Insurance Packages. While the law and 
regulation clearly identify palliative care as a right of patients with terminal illness, both 
are silent on the role of insurance providers. The explicit inclusion of palliative care 
interventions, medicines and other medical products in insurance packages will be 
essential to their availability and financial accessibility. The normative framework should 
clearly require health insurers to cover palliative care and associated institutions to offer it 
or otherwise facilitate access to it.  
 
Ensuring Inclusion of Patients with Prognosis Exceeding Six Months. The palliative 
care chapter of the health law explicitly leaves people with life-limiting illnesses who are 
not terminal unprotected even if they do require palliative care. The WHO definition of 
                                                          
222 Email correspondence with Dr. Gaspar Da Costa, Panama’s national palliative care coordinator, September 10, 2014. 
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palliative care does not contain any reference to life expectancy, instead focusing on 
patient need, and international human rights law grants people a right to appropriate 
health services to all. The government will thus need to determine how the healthcare 
system should address the palliative care needs of these patients. 
 
The limited prognosis requirement of the law is particularly problematic for pediatric 
palliative care. A life-limiting illness in a child has great impact on parents and siblings, 
making early initiation of care focused on quality of life care especially important. 
Furthermore, many children who require palliative care have neurological diseases, 
genetic conditions, congenital malformations, or degenerative disorders that undermine 
the quality of life of the child and the whole family over periods of time far beyond six 
months. 
 
Ensuring Access to Medicines. Changes to the normative base are finally required to 
ensure that home-based palliative care teams can carry these medicines on visits to 
patients. The government should use the WHO policy guidelines “Ensuring balance in 
national policies on controlled substance. Guidance for availability and accessibility of 
controlled medicines” in making these changes.223 
 
Preparing the Healthcare System for the Integration of Palliative Care 
As palliative care has traditionally not been part of Mexico’s healthcare system, a series of 
steps are required to ensure the building blocks for the delivery system are in place. 
Without adequate human resources, clinical protocols, availability of medicines, and other 
medical products and coverage by insurance providers, it will be impossible to build an 
effective and sustainable delivery system for palliative care. Thus, the government needs 
to prepare the system for the integration of palliative care, working with the healthcare 
institutions, health insurers, academia and other training institutes for healthcare workers, 
and civil society groups. 
 
Incorporating Palliative Care into Health Insurance Systems. In addition to introducing 
normative rules that require health insurers to cover palliative care, steps need to be taken 
to actually integrate palliative care interventions, and medicines into existing insurance 
                                                          
223 WHO, “Ensuring Balance in National Policies on Controlled Substance: Guidance for Availability and Accessibility of 
Controlled Medicines,” http://whqlibdoc.who.int/publications/2011/9789241564175_eng.pdf?ua=1.  
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packages and medicines lists. This includes revising Seguro Popular’s list of covered 
interventions to include palliative care and the medicines lists of Seguro Popular and IMSS. 
Given their importance in provision of home-based palliative care, all insurance providers 
should also ensure that home visits and consults by phone or video are adequately 
covered. 
 
Preparing Human Resources. The single greatest challenge is the preparation of 
adequate personnel to deliver palliative care. As noted above, very few healthcare workers 
are currently trained in this area. Most undergraduate training for health providers does 
not include any palliative care; availability of in-service training is very limited; and there 
are few continued education programs in palliative care. 
 
Making palliative care an integral part of health services offered in Mexico requires that all 
healthcare workers have at least basic knowledge of and skills in palliative care. This 
requires a systematic effort to train existing healthcare workers and to ensure that 
healthcare workers currently in pre-service training learn about palliative care during 
academic programs and as part of in-service training. 
 
We recommend that government undertake the following steps: 
 
• Work with associations of medical, nursing, pharmacy, psychology and social work 
faculties to ensure palliative care training is incorporated into relevant 
undergraduate curricula as a mandatory subject. 
 
• Work with academic hospitals to ensure that rotations in palliative care units and 
pain clinics become a standard element of residencies of healthcare workers, 
including for pediatricians in training. 
 
• Integrate palliative care training into continuing education programs for 
healthcare workers, including training in children’s palliative care. To allow a major 
scale-up of palliative care, all current healthcare workers need training in the 
basics of palliative care. A plan should be drawn up to use continuing education to 
bring such training to all healthcare workers, including those at children’s 
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hospitals, within the next few years, with a special focus on primary healthcare 
workers. 
 
• Recognize palliative care as a specialty/subspecialty of medicine. Recognition of 
palliative care as a (sub)specialty of medicine will accelerate training of healthcare 
workers and encourage academic research. 
 
• Recognize at least one hospital with a successful palliative care service in each 
state as a training site and invest in the capacity of these hospitals to conduct 
training activities.  
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Training Primary Care Providers in Panama 
Under Panama’s national palliative care program, a major investment was made into 
training of healthcare providers, with an emphasis on primary care givers. The program 
envisioned training and mentoring primary care givers over an extended period of time 
to gradually develop their ability to offer palliative care: 
 
It is expected that the degree of training of healthcare personnel will increase 
with time and that accordingly, they will be able to offer more complex care at 
each level of attention so that the need to refer patients from one level to the 
next is reduced.224 
 
The program identified different competencies healthcare providers should have after 
receiving different levels of training.  
 
Training Levels Competencies 
No training Identify and register cases of palliative care need and 
conduct visits every two weeks. 
Basic training Ability to develop an initial treatment and nursing plan, and 
to treat light symptoms and attend to patients in their final 
hours. 
Intermediate 
training 
Treatment of moderate symptoms; offering subcutaneous 
treatments; treat ulcers; and prevention of caregiver burn-
out or taking steps when no caregiver is available. 
Advanced training Treatment of severe symptoms; administration of 
intermittent sedation; address psychological distress and 
monitoring of quality of life. 
 
                                                          
224 National Palliative Care Program of Panama, p. 25. 
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The primary responsibility for training healthcare staff at the primary level lies with 
palliative care teams established in secondary level hospitals in each of Panama’s 
regions through programs of continuing education and hands-on mentorship of primary 
care givers. 
 
Under the program, a number of modules were developed for basic, intermediate and 
advanced training of current healthcare workers as well as government officials. 
Trainings were conducted both in-person and online. In total, more than 1200 people in 
Panama have received training in palliative care.225 
 
 
Medicines Availability. The government and insurance providers need to ensure that all 
essential medicines for palliative care for adults and children in all relevant formulations 
and dosages, as defined by the WHO, are included in the medicines lists of the Public 
Health Council and insurance providers. All these medicines should be approved for use at 
all levels of care and covered by insurance plans. The lists should follow the WHO Model 
List of Essential Medicines in grouping all essential palliative care medicines together in a 
section on pain and palliative care. 
 
Controlled Medicines. Ensuring availability and accessibility of controlled medicines, 
especially opioid analgesics, at all levels of care will be essential for the delivery of 
palliative care. Steps to improve their availability and accessibility should focus on 
drastically increasing the number of physicians that prescribe these medicines and 
pharmacies that dispense them and on resolving existing difficulties with prescribing and 
dispensing them. 
 
The ministry of health and COFEPRIS have already announced the introduction of an 
electronic system for issuing prescribing licenses and barcoded stickers to physicians, and 
for keeping records at pharmacies.226 The planned system has the potential for resolving 
many of the problems with licensing and barcoded stickers that currently exist.  
 
                                                          
225 Email correspondence with Dr. Gaspar Da Costa, Panama’s national palliative care coordinator, September 10, 2014. 
226 Announcement of the ministry of health and COFEPRIS of March 28, 2014, available at: http://t.co/DXLVO444PJ 
(accessed June 27, 2014). 
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A digital system could also lead to new barriers to prescribing these medicines, which will 
need to be avoided or addressed. Some of these are: 
 
- Avoid application fees or requirement to buy specific software or equipment. 
This would be a deterrent for many physicians and would likely result in limited 
numbers of prescribers. 
- Ensure system functions even in areas with frequent power outages and 
unstable or slow internet connections. It will be critical that the digital system 
can function well under varying conditions. 
- Address facilities without, or with limited internet access. There are many small 
health facilities in Mexico that currently do not have internet. 
 
The government has already announced that it would remove the requirement that 
physicians’ private addresses be included in prescription forms. It should finalize this 
step as soon as possible. Finally, the government should facilitate an uninterrupted and 
adequate supply of opioid analgesics, using the International Narcotics Control Board and 
WHO’s guide on estimates requirements for controlled medicines,227 and encourage the 
production of generic opioid analgesics which would both help keep down the cost of 
these medicines and help prevent stock-outs. 
 
Clinical Guidance. The Centro Nacional de Excelencia Tecnólogica en Salud (CENETEC), in 
cooperation with IMSS, issued a guide on clinical practice and a quick reference guide on 
palliative care in 2011.228 We recommend that the ministry of health and CENETEC ensure 
wide distribution of this clinical guidance as part of efforts to train healthcare workers and 
establish palliative care services. They should also convene periodic meetings of palliative 
care providers, primary care providers, and other relevant parties to review and update this 
clinical guidance. Clinical guidance needs to be developed for pediatric palliative care, 
                                                          
227 INCB and WHO, “Guide on Estimating Requirements for Substances under International Control,” 2012, 
http://www.incb.org/documents/Narcotic-
Drugs/Guidelines/estimating_requirements/NAR_Guide_on_Estimating_EN_Ebook.pdf (accessed July 15, 2014). 
228 The clinical guide can be found at: 
http://www.cenetec.salud.gob.mx/descargas/gpc/CatálogoMaestro/445_GPC_Cuidados_paliativos/GER_Cuidados_Paliativ
osx1x.pdf (accessed June 27, 2014). The quick reference guide can be found at: 
http://www.cenetec.salud.gob.mx/descargas/gpc/CatálogoMaestro/445_GPC_Cuidados_paliativos/GRR_cuidadospaliativo
s_4072011x2x.pdf (accessed June 27, 2014). 
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taking into consideration the 2012 WHO guidelines on the pharmacological treatment of 
persisting pain in children with medical illnesses.229 
 
Paving Way for Home-Based Palliative Care. Once conceptual questions around home-
based palliative care have been decided, steps will need to be taken to set up home-based 
palliative care teams, to ensure they can prescribe all essential palliative care and that 
home visits and phone or video consults are covered by insurance providers.  
 
Research and Data Collection. An investment should be made in research into the need 
for palliative care among adults and children and across different illnesses; availability 
and accessibility of palliative care; the effectiveness and efficiency of available services; 
and specific models of delivery. Such research will allow the government and health 
system to assess progress and make adjustments to policy or delivery systems as needed. 
We recommend, among others, the following steps: 
 
• Mexico should use the consumption of opioid analgesics per cancer death as an 
indicator to measure progress in the development of palliative care over time, as 
recommended by the WHO Global Action Plan on the Prevention and Control of 
NCDs.230 
 
• The Asociación Latinoamericana de Cuidados Paliativos has developed a set of 
indicators for assessing the availability of palliative care that measure progress in 
policy development, education, and drug availability.231 Using these indicators, 
Mexico could set a baseline and measure progress. 
 
• Hospitals should be required to report regularly on the availability of pain clinics 
and palliative care. These units/services should be included in organograms of 
hospitals. 
                                                          
229 WHO, “WHO Guidelines on the Pharmacological Treatment of Persisting Pain in Children with Medical Illnesses,” 
http://whqlibdoc.who.int/publications/2012/9789241548120_Guidelines.pdf. 
230 WHO, “WHO Global Action Plan on the Prevention and Control of Non Communicable Diseases for 2013-2020,”2014, 
http://www.who.int/nmh/events/ncd_action_plan/en/ (accessed on June 27, 2014). 
231 Asociación Latinamericana de Cuidados Paliativos, “Palliative Care Indicators 2013,” 2013, 
http://cuidadospaliativos.org/uploads/2013/3/Palliative%20Care%20Indicators%20ALCP%20(english).pdf (accessed on 
June 27, 2014). 
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Building the Delivery System 
Putting in place the delivery system for palliative care will undoubtedly be the most 
challenging part of implementing the law. As noted above, at present the number of 
palliative care services in Mexico is very limited and few healthcare workers have any 
training in the discipline, making it impossible to establish high quality palliative care 
services throughout the country and at all levels of care overnight. This will have to be a 
gradual process. 
 
It is, however, critical that the government show a strong commitment and strong 
leadership to initiate this process and keep it moving. Given the complexity of the task and 
the number of players involved it is essential that Mexico develop a mandatory 
implementation plan that assigns clear responsibilities and timelines, and includes 
accountability mechanisms. 
 
Palliative Care in Mexico State 
In 2009, Mexico State, then led by Mexico’s current president, Enrique Peña Nieto, 
launched a state palliative care program with the objective of developing palliative 
care units in hospitals in all districts of the state, and training primary healthcare 
workers in supporting patients requiring palliative care.232 The state’s health ministry, 
headed by Gabriel O’Shea, who now leads the National Commission on Social 
Protection in Health, hired a palliative care coordinator and assigned budget to 
develop a series of training and promotion activities. The state government also 
included palliative care in its development plan for 2011 to 2017 as part of its 
objective to improve the care for older persons and people with non-communicable 
diseases. 
 
By mid-2014, nine public hospitals in seven of the state’s 18 districts had opened 
palliative care units, including the state’s children’s hospital. Previously, palliative 
care was available only in one hospital in Toluca, the state capital. Each unit offers 
                                                          
232 Information in this text box is based on communication with Dr. Celina Castañeda, who was appointed as the state’s 
palliative care coordinator in 2009 and currently works in the subdivision for planning of the National Commission for Social 
Protection in Health. 
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both hospital-based care to inpatients and outpatients and home care for patients 
whose condition no longer permits them to come to the hospital. State officials expect 
to open palliative care units in hospitals in the remaining 11 districts by 2016. 
 
The program has also trained nurses from all public health clinics and hospitals in the 
state, a total of about 3,600 people, on principles of and basic skills in palliative care. 
Furthermore, it has worked with the National Polytechnic Institute and the 
Autonomous University of Mexico State to establish four diploma courses in palliative 
care for doctors, nurses, psychologists and social workers. 
 
The specifics of such plan will necessarily depend on decisions made regarding the 
normative and conceptual framework and the model(s) of care Mexico decides to 
implement. However, we believe that there are a number of key criteria the plan must fulfill 
in order to be effective. These include the following: 
 
• The national plan should set the overall strategy for the development of the 
delivery system. Each state should develop a specific state-level strategy that 
takes into account the specific circumstances of the state. Great variation between 
circumstances of different states and current development of palliative care 
services requires that implementation strategies are tailored.  
 
• The national and state plans should clearly identify the responsibilities of 
different institutions involved, including the state health department, health 
insurers, healthcare providers, and other relevant institutions. 
 
• The plans should establish specific targets and benchmarks against which 
progress can be measured. These should include targets and benchmarks for 
training of healthcare workers, establishment of multidisciplinary teams and 
palliative services, and on provision of palliative care at primary care level and at 
home. 
 
  111 HUMAN RIGHTS WATCH | OCTOBER 2014 
• The plans should establish strong accountability mechanisms. The health 
ministry and state departments of health should have final responsibility for 
implementation of the strategies and be required to report on a regular basis on 
progress made. The plans should grant the health ministry and health departments 
tools to impose sanctions, if needed, on institutions that are not complying with 
the implementation plan or law. We recommend that at the national and state 
levels specific officials are put in charge of the implementation plans. 
 
• The plans should make resources available for the implementation process.  
 
• Training of existing healthcare personnel should be one of the central 
components of the implementation plans. Training programs should, whenever 
possible, include classroom and bedside teaching; rotations into palliative care 
services; and mentoring. Training is likely to require the most significant resource 
investment. 
 
• The implementation strategies should build on existing palliative care services 
in each state. These services should play a key role in the training of healthcare 
providers, including through rotations and bedside teaching, setting up palliative 
care services at secondary and tertiary hospitals, and in putting together 
multidisciplinary palliative care teams. 
 
• The plans should include a clear strategy for integrating palliative care into 
primary care. This will require multidisciplinary palliative care teams at secondary 
level hospitals to support primary care providers, including a mentoring and 
referral system.  
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Appendix 1: Public Hospitals with Known Palliative Care 
Services in Mexico 
 
SSA: Ministry of Health        
IMSS: Mexican Social Security Institute      
ISSSTE: Institute of Security and Social Services for Employees of the State 
In black: Palliative care services 
In red: Pain clinic but no palliative care 
State Municipality Hospital Provider 
Aguascalientes Aguascalientes Hospital General Miguel Hidalgo SSA 
  Aguascalientes Hospital General de Zona N°1  IMSS 
 Aguascalientes Hospital General Calvillo SSA 
 Aguascalientes Hospital Tercer Milenio SSA 
Baja California Mexicali Hospital General SSA 
  Mexicali Unidad de Especialidades Médicas de 
Oncología (UNEME)  
SSA 
Baja California 
Sur 
La Paz Centro Estatal de Oncología Dr. Rubén 
Cardoza Macías  
SSA 
  La Paz Unidad Médica de Antención Ambulatoria La 
Paz (UMAA) 
IMSS 
Campeche Campeche Centro Estatal de Oncología de Campeche SSA 
Coahuila Saltillo Hospital Universitario Dr. Gonzalo Valdés State 
University 
Colima Colima Centro Estatal de Cancerología de Colima  SSA 
 Colima Hospital Regional Universitario University 
Chiapas Tuxtla 
Gutiérrez 
Hospital ISSTECH ISSTECH 
  Tuxtla 
Gutiérrez 
Hospital Regional Dr. Rafael Pascacio 
Gamboa,  
SSA 
Chihuahua Chihuahua Hospital de Pensionados ISSSTE 
  Chihuahua Centro Estatal de Cancerología Chihuahua  SSA 
Distrito 
Federal 
Benito Juárez Hospital 20 de Noviembre  ISSSTE 
  Coyocán Instituto Nacional de Pediatría SSA 
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  Cuauhtémoc Hospital de Oncología Centro Médico 
Nacional Siglo XXI  
IMSS 
  Cuauhtémoc Hospital General de Mexico Dr. Eduardo 
Liceaga 
SSA 
  Cuauhtémoc Hospital Infantil de México Dr. Federico 
Gómez 
SSA 
  Gustavo 
Madero 
Hospital 1o. de Octubre  ISSSTE 
 Álvaro Obregon Hospital Regional Lic. Adolfo López Mateos ISSSTE 
  Tlalpan Instituto Nacional de Cancerología SSA 
  Tlalpan Instituto Nacional de Neurología SSA 
  Tlalpan Instituto Nacional de Cardiología SSA 
  Tlalpan Instituto Nacional de Ciencias Médicas y 
Nutrición Salvador Zubirán 
SSA 
  Tlalpan Instituto Nacional de Enfermedades 
Respiratorias  
SSA 
  Tlalpan Instituto Nacional de Rehabilitación SSA 
  Tlalpan Hospital General Dr. Manuel Gea González SSA 
Durango Durango Centro Estatal de Cancerología de Durango SSA 
  Durango Hospital General 450 SSA 
  Durango Hospital General de Zona con Medicina 
Familiar (HGZMF) 1  
IMSS 
  Durango Clínica Santiago Ramón y Cajal ISSSTE  
Guanajuato Celaya Hospital General Celaya SSA 
  León Hospital Regional de Alta Especialidad del 
Bajío 
SSA 
  León Hospital General Regional de León ISSSTE 
  León Unidad Médica de Atención Especializada 
(UMAE) T1 León 
IMSS 
  San Miguel 
Allende 
Hospital General de San Miguel Allende  SSA 
Guerrero    
Hidalgo Pachuca Hospital General Pachuca SSA 
Jalisco Guadalajara Instituto Jalisciense de Cancerología SSA 
  Guadalajara Hospital Civil Juan I. Menchaca SSA 
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  Zapopan Instituto Jalisciense de Cuidados Paliativos y 
Alivio al Dolor (PALIA) 
SSA 
  Zapopan Hospital General de Occidente  SSA 
  Zapopan Hospital Regional Valentín Gómez Farias  ISSSTE 
  Guadalajara Hospital Civil Fray Antonio Alcalde SSA 
  Guadalajara Centro Médico de Occidente IMSS 
Mexico State Acolman Hospital para Enfermos Crónicos Tepexpan 
Gustavo Baz Prada 
SSA 
  Cuautitlán Hospital General de Cautitlán José Vicente 
Villada 
SSA 
  Ecatepec Hospital General Ecatepec José María 
Rodríguez 
SSA 
  Naucalpan Hospital Maximiliano Ruiz Castañeda SSA 
 Nezahualcóyotl Hospital La Perla SSA 
  Tlalnepanta Hospital General Valle Ceylán SSA 
  Toluca Hospital de General Dr. Nicolás San Juan SSA 
  Toluca Hospital para el Niño IMIEM State 
  Toluca Centro Oncológico Estatal del ISSEMYM State 
 Toluca Centro Médico “Lic. Adolfo López Mateos” SSA 
Michoacán Morelia Centro Estatal de Atención Oncológica de 
Morelia 
SSA 
  Morelia Hospital Dr. Miguel Silva  SSA 
Morelos Cuernavaca Hospital General Cuernavaca Dr. José G. 
Parres (Clínica de Algología) 
SSA 
  Emiliano 
Zapata 
Hospital de Alta Especialidad Centenario de 
la Revolución Mexicana 
ISSSTE 
  Emiliano 
Zapata 
Hospital del Niño Morelense  SSA 
  Cuernavaca Hospital General Regional 1 IMSS 
Nayarit Tepic Centro Estatal de Cancerología de Nayarit SSA 
  Tepic Hospital Civil Dr. Antonio González Guevara SSA 
 Ixtlan del Rio Hospital Integral de Ixtlan del Rio SSA 
Nuevo León Monterrey Hospital Universitario Dr. José Eleuterio 
González 
State 
University 
  Monterrey Hospital de Traumatología y Ortopedia 21  IMSS 
  Monterrey Hospital de Cardiología 34 IMSS 
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  Monterrey Hospital Regional de Especialidades 25  IMSS 
  Sabinas 
Hidalgo 
Hospital General Virginia Ayala de Garza  SSA 
  San Nicolás de 
Los Garza 
Hospital Metropolitano Dr. Bernardo 
Sepúlveda 
SSA 
Oaxaca Oaxaca Centro de Oncología y Radioterapia de 
Oaxaca 
SSA 
 Oaxaca Hospital General “Dr. Aurelio Valdivieso”  
  San Bartolo 
Coyotepec 
Hospital Regional de Alta Especialidad del 
Estado de Oaxaca  
SSA 
Puebla Puebla Hospital Universitario Universidad 
Autónoma de Puebla 
State 
University 
  Puebla Hospital Regional  ISSSTE 
Querétaro Querétaro Hospital General de Querétaro SSA 
  Querétaro Hospital de Especialidades del Niño y la 
Mujer FelIpe Núñez L. 
SSA 
Quintana Roo Benito Juárez Hospital General de Cancún Jesús Kumate 
Rodríguez 
SSA 
San Luis 
Potosí 
San Luis Potosí Hospital Universitario de San Luis (Hospital 
Central Dr. Ignacio Morones Prieto)  
SSA 
Sinaloa Culiacán Hospital General de Culiacán SSA 
  Culiacán Instituto Sinaloense de Cancerología SSA 
  Culiacán Manuel Cardenas de la Vega ISSSTE 
Sonora Hermosillo Hospital Oncológico del Estado de Sonora  SSA 
Tabasco Centro 
(Villahermosa) 
Hospital de Alta Especialidad Dr. Juan 
Graham Casasús 
SSA 
  Centro 
(Villahermosa) 
Hospital Dr. Daniel Gurria Urgell ISSSTE 
  Centro 
(Villahermosa) 
Hospital ISSET Dr. Julián Manzur Ocaña State 
  Centro 
(Villahermosa) 
Hospital Regional de Alta Especialidad Dr. 
Gustavo A. Rovirosa Pérez  
SSA 
Tamaulipas Tampico Hospital General de Tampico Dr. Carlos 
Canseco  
SSA 
  Victoria Hospital General Victoria Dr. Norberto 
Treviño Zapata  
SSA 
  Reynosa Hospital General de Zona 15 Reynosa IMSS 
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  Ciudad 
Maderro 
Hospital General Regional 6 Cd. Madero  IMSS 
  Victoria Unidad de Especialidades Médicas (UNEME) 
Centro Oncológico de Tamaulipas 
SSA 
Tlaxcala       
Veracruz Xalapa Clinica Hospital Xalapa ISSSTE 
  Veracruz Hospital Regional de Alta Especialidad de 
Veracruz  
SSA 
  Xalapa Centro Estatal de Cancerología Dr. Miguel 
Dorantes Mesa 
SSA 
  Veracruz Centro Médico Nacional Adolfo Ruiz Cortines IMSS 
Yucatán Mérida Hospital Regional de Alta Especialidad de la 
Península de Yucatán  
SSA 
Zacatecas Zacatecas Hospital General de Zona IMSS 
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Appendix 2: Comparison of WHO Essential Medicines List 
with Mexican Lists 
  
      
First Level First and 
Second 
Level
Second and 
Tertiary 
Level
Tertiary 
Level 
No 
Distinction 
Completely 
Lacking 
* Included in the Mexican medicines list, but is not available in Mexico. 
 
WHO List Formulation and Dose Public Health 
Council 
IMSS Medicines 
List 
Seguro Popular List 
  Basic List List for 
2nd and 
3rd level
 Basic Medicines 
List  
List of Fund for 
Catastrophic 
Expenses 
Acetylsalicylic 
Acid 
Tablet: 100 mg to 500 mg. 500mg  500mg 500mg,300mg 500mg, 300mg 
Suppository: 50 mg to 150 mg.      
Ibuprofen Tablet: 200 mg; 400 mg; 600 mg. Metamizol 
500mg 
 Metamizol 500mg 
Injectable Sol. 1 g/ 2 
ml
Metamizol 500mg 
Injectable Sol. 1 g/ 
2 ml 
Metamizol 
Injectable Sol. 1 
g/2 ml
Oral Liquid: 200 mg/5 ml.      
Paracetamol Tablet: 100 mg to 500 mg. 500mg  500mg 500mg 500mg 
Oral Liquid: 125 mg/5 ml. 100mg/ml  100mg/ml 100mg/ml  
Suppository: 100 mg. 300,100m  300mg 100mg, 300mg  
Codeine Tablet: 30 mg (phosphate).  Tramado
l 
Tablet 
37.5-
325mg, 
Injectabl
e 100mg
Tramadol 
Tablet 37.5-325mg, 
Injectable 100mg 
Tramadol 
Tablet 37.5-325mg, 
Injectable 100mg 
Tramadol  
Injectable 
Solution 100 
mg/2 ml 
 
Morphine Injection: 10 mg (morphine 
hydrochloride or morphine 
sulphate) in 1ml ampoules. 
 2.5mg/2.
5ml,10m
g, 
50mg/2
ml 
2.5mg/2.5ml,10mg, 
50mg/2ml 
2.5mg/2.5ml 2.5mg,50mg, 
10mg 
Oral Liquid: 10 mg (morphine 
hydrochloride or morphine 
sulphate)/5 ml
     
Tablet (immediate-release): 10 mg 
(morphine sulphate)
 30mg   30mg 
Tablet (slow release): 10 mg 200 mg 100mg 100mg 60mg 100 60mg*
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(morphine hydrochloride or 
morphine sulphate)*. 
60mg* 30mg* 
Granules (slow release; to mix with 
water): 20 mg to 200 mg (morphine 
sulphate). 
     
Amitriptyline Tablet: 10 mg; 25 mg; 75 mg. 25mg  25mg 25mg 25mg 
Cyclizine Injection: 50 mg/ml.      
Tablet: 50 mg.      
Dexamethasone Injection: 4 mg/ml in 1ml vials 
(disodium phosphate). 
8mg/2ml  8mg/2ml 8mg/2ml 8mg/2ml 
Oral Liquid: 2 mg/5 ml.      
Tablet: 2 mg [c]; 4 mg. .5mg  .5mg .5mg .5mg 
Diazepam Injection: 5 mg/ml.  10mg/2 10mg/2ml 10mg/2ml  
Oral Liquid: 2 mg/5 ml.  5ml    
Diazepam, 
cont’d 
Rectal Solution:2.5mg; 5mg; 10g.      
Tablet: 5mg; 10 mg  10mg 10mg 10mg  
Docusate 
Sodium 
Capsules: 100 mg.      
Oral Liquid: 50 mg/5 ml.      
Fluoxetine Solid Oral Dosage Form: 20 mg (as 
hydrochloride). 
20mg  20mg 20mg  
Haloperidol Injection: 5 mg in 1ml vial.  5mg/ml, 
50mg/ml
5mg/ml, 50mg/ml 5mg/ml, 50mg/ml  
Oral Liquid: 2 mg/ml.  2mg 2mg   
Solid Oral Dosage Form: 0.5 mg; 
2mg;
 5mg 5mg 5mg  
Hyoscine 
Butylbromide 
Injection: 20 mg/ml. Injectable 
20mg, 
tablet 
10mg
 Injectable 20mg/m, 
tablet 10mg 
Injectable 20mg/m, 
10mg/m 
 tablet 10mg 
 
Hyoscine 
Hydrobromide 
Injection: 400 micrograms/ml; 600 
micrograms/ml. 
     
Transdermal Patches: 1 mg/72 
horas
     
Lactulose Oral Liquid: 3.1 3.7 g/5 ml. Psyllium 
Powder 
49.7 g/100 
g
 Psyllium Powder49.7 
g/100 g 
Psyllium Powder 
49.7 g/400 g 
 
Loperamide Solid Oral Dosage Form: 2 mg. 2mg  2mg 2mg 2mg 
Metoclopramide Injection: 5 mg (hydrochloride)/ml 
in 2ml vial.
10mg/2ml  10mg/2ml 10mg/2ml 10mg/2ml 
Solid Oral Form: 10 mg 10mg 10mg 10mg 10mg
Oral Liquid: 5 mg/5 ml. 4mg 4mg/ml 4mg/ml 
Midazolam Injection: 1 mg/ml; 5 mg/ml 5mg/5ml 15mg/3ml 5mg/5ml
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, 
15mg/3
ml
15mg/3ml, 
50mg/10ml 
Oral Liquid: 2mg/ml [c]. 
Solid Oral Dosage Form: 7.5 mg; 15 7.5mg  
Ondansetron Injection: 2mg base/ml in 2ml 
ampoule (as hydrochloride). 
 8mg/4m
l 
8mg/4ml  8mg/4ml 
Oral Liquid: 4 mg base/5 ml. 
Solid Oral Dosage Form: 4 mg 
base/8 mg Base
 8mg 8mg   
Senna Oral Liquid: 7.5 mg/5 ml. Oral s. 200 
mg/100 ml
Granulated
54.2 g/300 
mg/100 g 
Tablet 8.6 
 200 mg/100 ml Oral Solution 200 
mg/75 ml Tablet 
8.6 mg 20 tablets 
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Doña Remedios Ramírez Facio, 73, who has pancreatic
cancer, shows a doctor at the palliative care unit of the
National Cancer Institute in Mexico how severe her
pain was before she was started on morphine.
Every year, tens of thousands of people in Mexico develop debilitating symptoms, such as pain, breathlessness and anxiety,
due to cancer, HIV/ AIDS, and other life-threatening health conditions. Although Mexico’s health law grants these people a right
to palliative care, only a few dozen public healthcare institutions across the country actually offer this health service. Most
healthcare personnel have received no training in the discipline, and few doctors are licensed to prescribe strong pain
medicines that are essential for palliative care. Consequently, many patients cannot realize their legal right to adequate
treatment and face great and unnecessary suffering.
“Care When There Is No Cure” identifies the challenges people with life-limiting illnesses in Mexico face accessing palliative
care, with a special focus on access to pain treatment. It analyzes current policies in the areas of healthcare, health insurance,
training of healthcare providers and medicine availability in light of Mexico’s international and national legal obligations.
The report urges the Mexican government to fully integrate palliative care into the public healthcare system, ensuring that this
health service and essential pain medicines like morphine are accessible to all patients who need them. 
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